Podcasts about Research

When I talk about Thriveology, many people say, “Oh, that is more of that ‘being happy' stuff, isn't it?" My response:  No. Well, not just that.  Sure, being happy is fine.  No need to avoid being happy! But that is only one dimension of life. It IS the dimension of life that hedonism celebrates and pursues.  If it feels good, do it.  Enjoy life.  Have a good time.  Seek out pleasure and avoid pain. Except that doesn't lead much to thriving. It posits your satisfaction with life externally to you.  It is THAT thing that makes you happy, brings you pleasure, makes life worthwhile. Eudaimonia was the counterpoint in greek thought.  This is the pursuit of life satisfaction by what things mean to you internally. It is how you bring meaning, enjoyment, and satisfaction into your life from within. And there is a cornerstone of that:  Contribution.  What we GIVE to the world, versus what we GET from the world. Giving versus Taking. Research has long pointed out the power of giving and contributing to the mental health, wellbeing, meaning/purpose, and satisfaction of people to their lives.  Which is why it is part of The Thrive Code. Listen below to learn why contribution matters and some principles of doing it. RELATED RESOURCES: Challenge Control Community Lee's Books

Today is the birthday of a man who gave our city one of its finest institutions: Arturo Alfonso Schomburg. His life's work led to the creation of the Schomburg Center for Research in Black Culture in Harlem. In order to learn more about the man behind the National Landmark, we are joined by Dr. Vanessa K. Valdés, author of Diasporic Blackness: the Life and Times of Arturo Alfonso Schomburg.

Screening tests are used to find breast cancer before it causes any warning signs or symptoms, when chances for survival are highest. It is important to stay on top of your breast health by knowing your risk, getting screened, knowing what is normal for you and making healthy lifestyle choices. Today's guest has a history of breast cancer on her mom's side and unfortunately lost her sister to the disease in 2013. Because of her family history, she started getting yearly mammograms early and when it was determined that she had cysts, that schedule changed to every 6 months. Because of this commitment to screening, her own breast cancer was caught early. Here today to share her story with us and how her family has helped her through is Terri James. Terri, welcome to the show!

Research shows after being distracted, it can take on average 23 minutes to completely refocus.  They can be anything at all, an email notification in the middle of a project, a text during a meeting or hang on, how about that interesting social media post that just popped up.  What happens next?  Well, you dive into that rabbit hole of intrigue and want to learn more - it happens to us all and then you lose focus on what you were doing, maybe you were just flowing with what you were doing before you got stopped?While some of us are unsuspectingly wishing for some sort of distraction from that dull task you've been trying to put off, some are nice to get whereas are just annoying and these may be affecting you more than you actually even realise.Continue to be inspired with the motivation to help you ‘level up' every day!Have you booked your FREE 30-minute LDL Call?  Head over to www.ldlcall.com to book your slot!  Or send me a text on 07801543515 and let's talk!Click here to listen to the previous episodes!https://podfollow.com/motivation-inspiration-from-learn-develop-live-with-chris-jaggs/view#_=_www.learndeveloplive.com

On this week's SciFiles, your hosts Chelsie and Daniel interview Merve Nur Kursav. She is currently a Ph.D. candidate in Mathematics Education at MSU and a research assistant in the Connected Mathematics Project (CMP) with anticipated graduation in Spring 2022. She received a graduate student award, and she has been recognized as a Fulbright Scholar and a Scholarship Undergraduate Teaching and Learning (SUTL) fellow. She is committed to promoting equity in mathematics and STEM education through research, teaching, and service. She has spent much of her career to date involved in all aspects of K- 16 mathematics and STEM education. The last decade of her life has seen her take many different academic and professional pursuits. Yet, through all of these experiences, one thing has been a constant: active ambassadorship of mathematics and STEM education. During her Ph.D. program, she has focused explicitly on statistical research methods and applied her theoretical knowledge in various mathematics and STEM education research projects [CMP, Instilling Quantitative and Integrative Reasoning (INQUIRE), and Scholarship Program for Retaining (SPRING)] and manuscripts. She has taken advanced methods courses and applied the skills she learned in these courses –both quantitative and qualitative–to her work on various projects. Inspired by her own experiences, she had the privilege to recognize the complex challenges faced by different populations of students in mathematics and STEM education fields. Her academic work reflects her commitment to working with all students, regardless of ethnic, racial, linguistic, and cultural backgrounds. With this commitment in mind, she designed a mixed-methods dissertation study focusing on teachers' beliefs, perceptions, experiences, and strategies for teaching and engaging English Learners (ELs) in 6-12 grades mathematics classrooms using Culturally Responsive Pedagogy as her theoretical framework. Her dissertation study will set the stage for determining what teachers' beliefs and practices in teaching mathematics to ELs are. She plans on using the findings from her dissertation study and plans future studies that will involve intervention and professional development for mathematics teachers of ELs. Being an educator of mathematics teaching is a high honor for her. In her teaching, she thinks that she is not only contributing to who her students (future teacher educators) become as individuals, but she has a powerful opportunity to guide them in embracing the diverse world. She has always believed that by knowing who we are, acknowledging our own beliefs and actions, and admitting the existence of inequities and injustices, we can do our part to make a change. She hopes to become a catalyst for change in the teaching and learning of mathematics. She is also engaged in the professional community and service to the field. For example, she is one of the founding members of the Critical Philosophical and Psychoanalytical Institute for Mathematics Education and Journal for Theoretical and Marginal Mathematics Education. She has been a representative to MSU Student Advisory Council and Diversity, Equity, and Inclusion Advisory Committee. If you're interested in talking about your MSU research on the radio or nominating a student, please email Chelsie and Danny at scifiles@impact89fm.org. Check The Sci-Files out on Twitter, Facebook, Instagram, LinkedIn, and YouTube! 

Pat Mayo provides a quick preview and makes his early 2022 Farmers Insurance Open Picks in a his first look and research for this week's PGA event. Get 20% All DK Tools/Stat Engine: https://www.fantasynational.com/mayo NFL Stats & Tools Code “MAYO” for discount: https://www.runthesims.com/mayo Use code MMN at Prize Picks for a deposit match up to $100: https://bit.ly/PrizePicksMMN Join Mayo Media Newsletter: https://mayomedia.substack.com/people/32468255-mayo-media Sub to the Mayo Media Network: https://bit.ly/YTMMN NFL Stats & Tools Code “MAYO” for discount: https://www.runthesims.com/mayo NFL RESEARCH: https://youtu.be/YwfMLloiX1k How to Play NFL DraftKings, Strategy & Tips: https://youtu.be/pXkjPOwv5I4 SHOW INDEX 00:00 Intro 0:38 Tourney Notes 3:31 Field 4:39 Course 8:38 Event History 18:20 Stats + Model 31:18 7400+ Yard Courses 38:55 SG: Torrey Pines South 46:11 Guess The Odds Apple: http://bit.ly/PMEiTunes Spotify: https://goo.gl/VboemH Stitcher: http://goo.gl/Ft3Gmr Google: http://bit.ly/GooglePodPME Castbox: http://bit.ly/PMECastbox Pat Mayo Twitter: https://twitter.com/ThePME Pat Mayo Facebook: https://www.facebook.com/ThePME Pat Mayo Instagram: https://www.instagram.com/thepme/

When did you first realize you were creating and deploying thought leadership?   Many thought leadership practitioners were unknowingly performing the function before they stepped up to the title. However, adding the words “Thought Leader” to your title shines a particular spotlight on your talents. The title often comes with high expectations — and a need for clear metrics to show that your work makes sense. To explore how a new thought leadership role can be developed, and how to help it evolve and move forward, we turn to Clarinda Cerejo, Senior Director of Thought Leadership at Cactus Communication, a technology company that is accelerating scientific advancement by making research available to communities around the world. Clarinda tells us how Cactus Communication supported her work developing a formal thought leadership role, from the earliest days of research to the expansive plan of building communities. She also discusses what it meant to both her and her organization when she finally included the words “thought leadership” in her formal title. Determining what success looks like for thought leadership can be challenging. Clarinda gives clear examples of metrics you can use, why you need to celebrate the small victories, and how success is cumulative. Thought leadership means being invested in the long haul, and watching trends, not fads. We examine the work Clarinda is doing, and the challenges she has faced in moving from scientific research to content marketing. She carries the scientific method into her work doing community building, helping others get their work published, and navigating the difficult peer-review process. This conversation is a perfect example of the arc a career can take, from subtly doing thought leadership to steering the ship for your company. Listen in, and get insights from one of the most insightful new thought leaders in the business! Three Key Takeaways: * Remember that the external perception of your role is more important than any title. Do the work - recognition will come!   * Success in Thought Leadership often looks different than success in marketing or sales. Celebrate the small victories, because they will add up to big changes. * Focusing Thought Leadership on community lets you create content that gives voices to those who have been most impacted.

Why and when am I consuming a large amount of protein in one sitting? There is a great reason and I share that today along with wrapping up the first week of my weight loss journey in 2022.

Guest Rob Boyce, Accenture's Global Lead for Cyber Incident Response and Transformation Services, joins Dave to discuss joint research done by Accenture's Cyber Threat Intelligence (ACTI) group and Prevailion's Adversarial Counterintelligence Team (PACT). The teams dug into recently publicized campaigns of the cyber espionage threat group Lyceum (aka HEXANE, Spirlin) to further analyze the operational infrastructure and victimology of this actor. The team's findings corroborate and reinforce previous ClearSky and Kaspersky research indicating a primary focus on computer network intrusion events aimed at telecommunications providers in the Middle East. Additionally, the research expands on this victim set by identifying additional targets within internet service providers (ISPs) and government agencies. Although all victim-identifying information has been redacted, this report seeks to provide these targeted industry and geographic verticals with additional knowledge of the threat and mitigation opportunities. The research can be found here: Who are latest targets of cyber group Lyceum?

In 2022, the U.S. Supreme Court could overturn Roe v Wade, imperiling all women's freedoms, and creating a new pipeline to prison for the vulnerable just as the world is learning how counterproductive most incarceration - solutions are. Today's guests argue that things could have been very different. If the white dominated “choice” movement had paid closer attention to all women's choices, or lack thereof; If anti-violence advocates had rejected criminalization and incarceration as a solution to the violence in women's lives. Things could have been different, our guests argue, if a different part of the US women's movement had gained more attention - attention it is beginning to get now. There has always been such a movement, they know, because they were there. Today we talk to Black abolitionist feminist Beth Richie and Queer southern feminist Suzanne Pharr have worked together, for abolition, feminism, and a systemicly different world for forty years.  What have they learned? And what is their message for us now, when so much hangs in the balance?Guests:Suzanne Pharr, Co-founder, Southerners on New Ground. Author, Transformation: Toward a People's DemocracyBeth Richie, Director, Institute for Research on Race & Public Policy, University of Illinois at Chicago. Author, Compelled to Crime: the Gender Entrapment of Black Battered Women & Abolition. Feminism. Now. Full episode notes are posted at https://Patreon.com/theLFShow   Patreon Members receive early access to the FULL UNCUT INTERVIEW with ARUNDHATI ROY from last week's podcast and the entire full uncut 1 hour conversation with Suzanne Pharr & Beth Richie from this week's podcast.  We are independent and community funded, please consider becoming a member and sharing your thoughts at Patreon as a member.  Non-members do have access to the episode notes and later access to  full uncut interviews.  

Heather and Maureen return this week for part two of their 2021 Breastfeeding Year in Review series to discuss some more of the most interesting lactation studies of 2021! Listen in to learn about newly found benefits linked to lactation, COVID-19 and breastmilk research. You don't want to miss this one!  THANK YOU TO THIS EPISODE'S SPONSORSClick HERE to order Liquid IV! Use promo code MILKMINUTE for 25% off your order and free shipping.Click HERE to get Happi Tummi and enter code MILKMINUTE10 for 10% off your order! Get your breastfeeding journey BACK ON TRACK with a Lactation Consult with Heather! Telehealth available and some insurance accepted. Click the link below for the deets.Click here to Work with HeatherListener Question: Listener had a question about daytime feeds and wanted to know if it's normal for a child to feed frequently for short periods of time, lots of starting and stopping.Find the new Milk Minute Podcast website by clicking here!Become a Milk Minute VIP: Click here to get behind-the-scenes-access and exclusive merch!Contact us: To send us feedback, personal stories, or just to chat you can send us an email at milkminutepodcast@gmail.comGet Community Support: Click Here to Join our Free Facebook Community!Stay up to Date: Find us on INSTAGRAM @milk_minute_podcastPrefer to read the transcript?- Click Here to read the edited version of this episode!Previous episodes of The Milk Minute Podcast mentioned in this episode:Milk Minute Ep. 72- Black Breastfeeding Equity and Opportunity for ChangeResources:Does breastfeeding protect children from COVID-19?COVID-19: Relationship and Impact on Breastfeeding COVID-19 Vaccine in Pregnant and Lactating WomenCHILD Cohort StudyUCLA Health StudyScience DirectThe Critical Window of Opportunity: Lactation Initiation Following Cesarean BirthIndiana University Study on Lactation CookiesSupport the show (https://www.patreon.com/milkminutepodcast)

Each day, more than 130 people die from opioid overdoses. Opioids are a class of drugs that include prescription pain relievers like oxycodone. They also include illegal drugs like heroin. In 2019, 1.6 million Americans had an opioid addiction. This is also known as opioid use disorder. Yet effective medications—like buprenorphine, methadone, and naltrexone—are prescribed to only a fraction of people with opioid use disorder. Patients often receive such medications in an opioid treatment program. Methadone, for example, can only be given in a certified treatment program. Primary care physicians can apply for a waiver to prescribe buprenorphine. However, less than 10% of U.S. primary care providers have a buprenorphine waiver. Given the limited number of patients that each physician can treat, involving pharmacists in opioid treatment may improve access. The Doctor Patient Forum's Mission Statement is to advocate, educate, and defend the rights of patients, to protect all providers (including prescribers and pharmacists) who tirelessly work to treat their patients, and to bring awareness to the general public regarding restrictions upon medical providers. We are fighting for a return to individualized patient care instead of using guidelines and laws based on little evidence using arbitrary thresholds. Contrary to what has been said, we are not “industry funded.” We haven't taken any money from pharma. We are not being paid to promote opioids. We are simply chronic pain and illness patients who are fighting as hard as we can to effect change in this broken system where the patient's voice is non-existent. For part 4 of the series, we're honored to have Ms. Bev Schechtman. Ms. Schectman is one of the founding members of Don't Punish Pain Rally and is the VP of The Doctor Patient Forum. She grew up in northern New Jersey, and has lived in the Raleigh area in North Carolina since 2009. Bev has been married to Randy for 18 years, and has two teenage daughters, Emma, 17, and Livvy,13. She also has a 3-year-old Aussidoodle, Griffin. Bev has been living with Crohn's Disease and Psoriatic Arthritis for over two decades. She first contacted Claudia Merandi after being denied opioid medication while hospitalized for kidney stones in 2017.She was denied due to being a survivor of childhood sexual abuse. Bev is a passionate advocate for people with chronic pain and illness as well as those who have PTSD/ survived sexual assault/abuse. Bev has her B.A. in Psychology and hopes to get her M.S.W. in the near future. Bev is a voracious reader and researcher. She is passionate about understanding why pain patients are being mistreated so she can educate other patients and empower them to fight back. Bev hopes her advocacy work brings awareness to the anti-opioid zealots who are profiting off of punishing pain patients while pretending to care about those with addiction. She also believes strongly in Harm Reduction efforts. Learn more about your ad choices. Visit megaphone.fm/adchoices

Kyle and Matt sit down to continue their two-part series on the 12 ways to help pastors thrive. On today's episode, the guys discuss six things churches can do to help their pastors not just survive, but thrive in ministry. Last week, we considered six things pastors can do. These insights come in light of some recent work by Lifeway Research.Research: https://lifewayresearch.com/2015/09/01/despite-stresses-few-pastors-give-up-on-ministry/Article: https://lifewayresearch.com/2022/01/06/12-ways-to-help-a-pastor-stay-in-ministry/Replanting Rural Churches: https://amzn.to/3F2p80GBig thank you to SWBTS and CSB for their generous support of our podcast. Be sure to check out the Preview Day for Southwestern Seminary: https://texasbaptist.com/preview-day/

Questions on Protecting Wealth with Gold & Silver? Call 877-410-1414 or Schedule a Call for Later Here: ↓ https://calendly.com/itmtrading/youtube?utm_source=YouTube __________ To see Lynette's slides and research links from this video: https://www.itmtrading.com/blog/pension-plans-on-the-brink-headline-news-with-lynette-zang/ Follow Lynette Zang ⬇️ Instagram: https://www.instagram.com/lynettezang/ Twitter: https://twitter.com/itmtrading_zang Podcast: https://anchor.fm/itmtrading __________ Find out if you're properly protected today... ITM TRADING: Helping Build Your Future, Freedom, and Legacy Call Today for Your 1st Strategy Session: 877-410-1414 You can also email us at: Services@ITMtrading.com All Our Videos and Research: https://www.ITMTrading.com/Blog Homepage: https://www.ITMTrading.com ITM Trading Twitter: https://twitter.com/itmtrading Lynette Zang Twitter: https://twitter.com/itmtrading_zang Facebook: https://facebook.com/ITMTrading By ITM Trading's Lynette Zang Call Us Direct for Long-Term Gold & Silver Strategies: 877-410-1414 ITM Trading Inc. © Copyright, 1995 - 2022 All Rights Reserved.

Emily Bazelon, John Dickerson and David Plotz discuss Biden's first year, SCOTUS's block of OSHA's vax-or-test rule, and Virginia Governor Glenn Youngkin's busy start. Here are some notes and references from this week's show: John Dickerson for CBS Sunday Morning: “President Joe Biden: The First Year” Station Eleven, by Emily St. John Mandel  Station Eleven series on HBO Max Here's this week's chatter: Emily: Deep Cover, Season 2: Mob Land John: Take Note Podcast; Adam Webb for Take Note: “How to Keep a Notebook” David: Paul Schwartzman for The Washington Post: “Missing Jewels And Art: A Lawsuit Against a Retired Professor Is Ruffling The Well-To-Do From Georgetown to Newport, R.I.” Listener chatter from Alissa Surges: Allison Robicelli for The Washington Post: “I Spent The Night in an Empty Airport. it Was a Dream Come True”; Work at City Cast For this week's Slate Plus bonus segment Emily, John, and David talk about why to keep a journal.   Tweet us your questions and chatters @SlateGabfest or email us at gabfest@slate.com. (Messages may be quoted by name unless the writer stipulates otherwise.) Podcast production by Jocelyn Frank. Research and show notes by Bridgette Dunlap. Learn more about your ad choices. Visit megaphone.fm/adchoices

Emily Bazelon, John Dickerson and David Plotz discuss Biden's first year, SCOTUS's block of OSHA's vax-or-test rule, and Virginia Governor Glenn Youngkin's busy start. Here are some notes and references from this week's show: John Dickerson for CBS Sunday Morning: “President Joe Biden: The First Year” Station Eleven, by Emily St. John Mandel  Station Eleven series on HBO Max Here's this week's chatter: Emily: Deep Cover, Season 2: Mob Land John: Take Note Podcast; Adam Webb for Take Note: “How to Keep a Notebook” David: Paul Schwartzman for The Washington Post: “Missing Jewels And Art: A Lawsuit Against a Retired Professor Is Ruffling The Well-To-Do From Georgetown to Newport, R.I.” Listener chatter from Alissa Surges: Allison Robicelli for The Washington Post: “I Spent The Night in an Empty Airport. it Was a Dream Come True”; Work at City Cast For this week's Slate Plus bonus segment Emily, John, and David talk about why to keep a journal.   Tweet us your questions and chatters @SlateGabfest or email us at gabfest@slate.com. (Messages may be quoted by name unless the writer stipulates otherwise.) Podcast production by Jocelyn Frank. Research and show notes by Bridgette Dunlap. Learn more about your ad choices. Visit megaphone.fm/adchoices

Getting a disease is inevitable; no one is exempt from it. Some people are fortunate enough to be cured of their illnesses. However, some diseases and conditions do not have cures, such as cancer.  In a pandemic-stricken world, a deeper understanding of our immune system is crucial now more than ever. The body's immune system is the body's primary defence against sickness and disease. By learning the inner workings of our body, we can help support and prepare ourselves to fight cancer and keep ourselves healthy.  In this episode, Dr Elizabeth Yurth shares her knowledge on the effects of cancer and viruses on our immune system. She talks about alternative approaches based on scientific evidence that goes hand in hand with traditional cancer treatments, ranging from spermidine to vitamin D and zinc. Become pre-emptive and preventive when it comes to your health! Get ahead of diseases through early diagnosis.  If you want to learn more about how you can help your immune system fight cancer and other diseases, then this episode is for you!   Here are three reasons why you should listen to the full episode:   Understand how your immune system works against viruses and cancer cells. Learn more alternative approaches to cancer treatment aside from chemotherapy and radiation. Discover how early testing and screening can help improve your overall health.   Get Customised Guidance for Your Genetic Make-Up For our epigenetics health programme, all about optimising your fitness, lifestyle, nutrition and mind performance to your particular genes, go to  https://www.lisatamati.com/page/epigenetics-and-health-coaching/. Customised Online Coaching for Runners CUSTOMISED RUN COACHING PLANS — How to Run Faster, Be Stronger, Run Longer  Without Burnout & Injuries Have you struggled to fit in training in your busy life? Maybe you don't know where to start, or perhaps you have done a few races but keep having motivation or injury troubles? Do you want to beat last year's time or finish at the front of the pack? Want to run your first 5-km or run a 100-miler? ​​Do you want a holistic programme that is personalised & customised to your ability, goals, and lifestyle?  Go to www.runninghotcoaching.com for our online run training coaching. Health Optimisation and Life Coaching Are you struggling with a health issue and need people who look outside the square and are connected to some of the greatest science and health minds in the world? Then reach out to us at support@lisatamati.com, we can jump on a call to see if we are a good fit for you. If you have a big challenge ahead, are dealing with adversity or want to take your performance to the next level and want to learn how to increase your mental toughness, emotional resilience, foundational health, and more, contact us at support@lisatamati.com. Order My Books My latest book Relentless chronicles the inspiring journey about how my mother and I defied the odds after an aneurysm left my mum Isobel with massive brain damage at age 74. The medical professionals told me there was absolutely no hope of any quality of life again. Still, I used every mindset tool, years of research and incredible tenacity to prove them wrong and bring my mother back to full health within three years. Get your copy here: https://shop.lisatamati.com/collections/books/products/relentless. For my other two best-selling books Running Hot and Running to Extremes, chronicling my ultrarunning adventures and expeditions all around the world, go to https://shop.lisatamati.com/collections/books. Lisa's Anti-Ageing and Longevity Supplements  NMN: Nicotinamide Mononucleotide, an NAD+ precursor Feel Healthier and Younger* Researchers have found that Nicotinamide Adenine Dinucleotide or NAD+, a master regulator of metabolism and a molecule essential for the functionality of all human cells, is being dramatically decreased over time. What is NMN? NMN Bio offers a cutting edge Vitamin B3 derivative named NMN (beta Nicotinamide Mononucleotide) that can boost the levels of NAD+ in muscle tissue and liver. Take charge of your energy levels, focus, metabolism and overall health so you can live a happy, fulfilling life. Founded by scientists, NMN Bio offers supplements of the highest purity and rigorously tested by an independent, third-party lab. Start your cellular rejuvenation journey today. Support Your Healthy Ageing We offer powerful third-party tested NAD+ boosting supplements so you can start your healthy ageing journey today. Shop now: https://nmnbio.nz/collections/all NMN (beta Nicotinamide Mononucleotide) 250mg | 30 capsules NMN (beta Nicotinamide Mononucleotide) 500mg | 30 capsules 6 Bottles | NMN (beta Nicotinamide Mononucleotide) 250mg | 30 Capsules 6 Bottles | NMN (beta Nicotinamide Mononucleotide) 500mg | 30 Capsules Quality You Can Trust — NMN Our premium range of anti-ageing nutraceuticals (supplements that combine Mother Nature with cutting edge science) combats the effects of aging while designed to boost NAD+ levels. Manufactured in an ISO9001 certified facility Boost Your NAD+ Levels — Healthy Ageing: Redefined Cellular Health Energy & Focus Bone Density Skin Elasticity DNA Repair Cardiovascular Health Brain Health  Metabolic Health My  ‘Fierce' Sports Jewellery Collection For my gorgeous and inspiring sports jewellery collection, 'Fierce', go to https://shop.lisatamati.com/collections/lisa-tamati-bespoke-jewellery-collection. Episode Highlights 01:04 Lisa's Journey with Cancer and her Mom Lisa's mother has been diagnosed with high-grade diffuse B-cell lymphoma. These recent events have motivated Lisa to delve deeper into cancer research. Understanding how cancer works and the approaches besides traditional procedures such as chemotherapy and radiation are necessary and relevant. In the following episodes, she will be doing a series of interviews revolving around the theme of cancer. 09:12 How Cancer Rewrites the Definition of Healthy When diagnosed with cancer, building muscles and promoting metabolic activity becomes less of a priority. The goal of cancer treatment is to slow everything down. We want to get rid of damaged cells and generate new ones. Dr Yurth adds that while it is vital to maintain glucose levels and everything, the general goal is to block muscle growth. Cancer begins at a mitochondrial level, and cancer cells need tons of energy to support their growth rate. We need to block all the typical pathways that make us healthy to stop its growth. 12:58 Spermidine and Autophagy Pathways  The effects of spermidine are different for different types of cancer, but it appears to be very beneficial to patients suffering from colon cancer. Blocking the polyamine pathways in prostate cancer has been good in getting rid of cancer cells. A high dose of spermidine will result in a dramatic autophagy effect. However, Dr Yurth advises that she wouldn't recommend this until research reveals more information.    Another good approach is doxycycline. Mitochondria started as bacteria and have their own DNA. Since doxycycline is an antibacterial agent, it works well in getting rid of these mitochondria. Dr Yurth advises us to stick to approaches that have better answers. 17:19 Autophagy as Recycling  Cancer cells can use recycled proteins as another fuel source, so it's vital to block these pathways. Dipyridamole is a drug that works well in blocking nucleotide salvage pathways. However, chemotherapeutic drugs work on only one pathway, and cancer cells tend to find other pathways to get their energy, which makes working against these cells challenging.  19:00 Fight Cancer By Starving It Dr Yurth remarks that McClellan's work that includes safe, inexpensive, and readily available drugs in combating cancer is an innovative approach. She recommends doing them hand in hand with conventional approaches to cancer. Most oncologists will discourage patients from taking unconventional practices with cancer treatments. 21:25 Taking Others' Input, Making Own Decisions We need new scientific research about making decisions about cancer treatment. For example, there may be detrimental effects to patients undergoing unconventional approaches. Dr Yurth adds that she does extensive research in everything she does.  23:00 Drug Interactions Understanding drug interactions is vital in understanding cancer treatments. However, oncologists only look at it at the metabolic cellular level and follow their study protocols.  23:34 Understanding the Metabolism of Cancer Cancer is not just a genetic disease. While genetics causes a disposition towards cancer, the disease itself starts in the mitochondria. The mitochondria are independent and can become cancerous. There is no homogenous pattern when it comes to cancer cells mutating. That is why we need to treat the mitochondria and target metabolism.   26:20 Progress in Understanding Cancer There has been headway in understanding cancer, but you'll realise that research in the field has gotten further if we put everything together. The immune system responds appropriately to keep the cancer cells in check. However, as we age, the immune system becomes dysfunctional and can no longer get rid of cancer cells. Cancer is an age-related disease because the immune system starts to deteriorate. Viruses like cytomegalovirus, Epstein Barr virus (EBV), and COVID end up sticking around and dysregulating the immune system. Over time, these viruses can eventually link to a form of cancer.    28:40 Viruses and their Relationship to the Immune System Over time, the immune system becomes depleted in keeping check with viruses in the body. The ratio of neutrophils and lymphocytes is vital for keeping your immune system working well. Having disproportionate lymphocytes means that your immune system can't protect your body from viruses. Dr Yurth shares that her son's white blood cell count dropped after experiencing EBV and COVID at the same time. Many people don't appreciate how viruses play a role in the long haul in our immune system. Dr Yurth suggests looking more aggressively at latent viruses in the body. Getting a simple CBC can determine how your immune system is currently faring.  33:53 What Peptides Are  Peptides are, in a sense, small proteins. A protein has more than 50 amino acids, and peptides have less than 50 amino acids. Our body makes thousands of peptides, each made with a specific function. Synthetic peptides are also present in the body. The thymus gland, responsible for producing peptides, becomes smaller as we age. For patients with autoimmune diseases, giving back peptide thymosin alpha 1 in doses helps their immune system fight viruses. Some countries use a drug called Daxon for this purpose or as an adjunct to vaccines. Immune system support is critical for cancer patients going through chemotherapy. However, this remains an expensive and inaccessible approach.  39:12 Emerging Home Diagnostic Tests in the Market It is vital to get ahead and find early signs of diseases through testing. Dr Yurth shares an anecdote of her patient with dementia. There is a correlation between the brain scan and the immune system test results, which pointed towards a viral influence. Your lymphocyte count can be the marker in determining the status of your immune system.    40:52 Being Pre-emptive and Preventive Your GP typically has you undergo a CBC test, but the results of this test tend to go overlooked. The risk of dying becomes dramatically higher when your blood count is above 1.5 to 1. Albumin dropping is a sign that the body is in a stressed state. This marker predicts if your body will respond well to cancer. Cell size and red blood cell distribution can also help healthcare providers determine the health status of your cells.  43:13 Background on Dr Yurth's BLI Academy Course  The course will be available in January and includes a blood test. Dr Yurth and her team will walk you through your test results and the possible diseases you need to consider. It's essential to look for markers that tell you if something's wrong with your body. There are long term ramifications to latent viruses such as EPV, which could lead to lymphoma. 46:25 COVID and How You Can Support the Immune System Vitamin D is essential to support your immune system fight viruses, and by extension, fight cancer and the coronavirus. Dr Yurth recommends 1000 IU/day of Vitamin D and taking it with Vitamin K2 intracellularly. People lacking a binding protein may experience issues taking Vitamin D naturally through sunlight exposure. Fortunately, there are substitutes, including certain wavelength lamps and supplements. Sunlight exposure and vitamin D influences the frequency of colds and flu in winter. The vitamin D levels from the sun decrease during this season.  50:07 The Importance of Vitamin D  Vitamin D upregulates an antimicrobial peptide, LL 37, which fights infections. Instead of buying expensive LL 37, you can take more vitamin D and upregulate your own LL 37. It is a great antiviral agent as well. Some people fear getting too much vitamin D. However, studies have shown that you need to be taking massive amounts before it becomes toxic. Dr Yurth recollects the case of a patient taking around 500,000 IU/day. When she stopped taking massive amounts, her levels went back to normal. 52:17 The Problem with Taking Vitamin D Naturally Wearing sunblock can protect us from skin cancer and wrinkles but can also affect vitamin D absorption. African Americans and people of Mediterranean origin have skin less likely to be damaged by sun rays but tend to have lower vitamin D levels. In contrast, people who have Norwegian and similar European origins have higher vitamin D levels because their bodies aren't under the sun all the time. Through testing, you can determine if you need more vitamin D in your body.  53:54 The Importance of Zinc Viruses use your zinc to replicate. Zinc deficiency is present in people who contracted COVID, causing loss of taste and smell. A smell test is employed to determine whether a person has zinc deficiency. Higher levels of zinc can help protect our bodies against viral infections. Dr Yurth recommends a 1:1 zinc and copper ratio. You can add 2 milligrams of copper along with your zinc intake or use copper peptide face creams to achieve this recommendation. Some patients can take GHK Copper peptide intravenously or topically.  56:52 Quercetin and Resveratrol Quercetin helps get zinc into the cell. Resveratrol and Quercetin also help in treating viruses. These drugs also block glucose transport which makes them beneficial in treating cancer.  57:52 Honokiol or Magnolia Bark Extract and Zeolite Also known as Relora, it is an immune-modulating agent with antiviral properties. The drug has an adrenal function; it relieves stress and calms down cortisol present in the body at night. Zeolite is volcanic ash that forms a negatively charged structure upon hitting the water. Dentists commonly use it for mercury detox. Its cage-like structure can trap harmful toxins and viruses that get into our bodies. It also has anti-cancer properties. Ingesting zeolite while undergoing chemotherapy is not recommended because it can get rid of the toxins present in the treatment.  1:02:04 Mental Work in the Cancer Journey As a caretaker, stress shows prominent signs in physical and mental health. Dr Yurth shares that when her mother died in September, her father's prostate cancer was exacerbated by stress, which eventually led to his death. Similarly, Lisa's family experienced the loss of her father, followed by her mother's cancer diagnosis. Don't neglect the mental side of cancer.    Resources Gain exclusive access and bonuses to Pushing the Limits Podcast by becoming a patron!  How to Starve Cancer by Jane McLelland Visit Lorraine Picard's website for copper peptide creams here. Interested in BLI Academy Courses? Check out their offered services here. Learn more from Dr Elizabeth Yurth from her previous podcast episodes: Episode 187: Back to Basics: Slow Down Ageing and Promote Longevity with Dr Elizabeth Yurth Rethinking the Function of Mitochondria for Our Health with Dr Elizabeth Yurth You can also check out Dr Elizabth Yurth's podcast with the Boulder Longevity Institute here! Connect with Dr Elizabeth Yurth: Instagram l LinkedIn   7 Powerful Quotes “What happens in cancer though, is we have this accumulation of damage. And so now we have to go really aggressively at getting rid of everything that's allowing cell growth.” “Neutrophils, think of them as your chronic inflammatory and lymphocytes are your innate immune system. When your innate immune system starts to become taxed and not functioning well, then you'll start to see your lymphocyte count drop,” “I'm never an advocate of saying, Don't do all traditional approaches, because I do think there's some value to them, but we want to support the body along with it.” “And yet, we know that for every point above 1.5, to 1 that your risk of dying goes up considerably. You know, it's dramatic. And there are other little signs too, that things are going awry.” “(A higher risk) happens as we get older because our immune system is now taxed for so long. So if we could say okay, yes, you had this virus, let's try and eradicate it. Let's keep your immune system as healthy as it can, you know, until 150.” “The data really supports that if your vitamin D is robust, your likelihood of getting sick is really small.” “The studies have shown that it has to be taking massive amounts of (vitamin D) to ever become toxic. So at 10,000 IU/day, nobody is going to become toxic. You really honestly don't have to worry.”   About Dr Yurth Dr Elizabeth Yurth is the co-founder and medical director of the Boulder Longevity Institute.  Dr Elizabeth Yurth has more than 25 years of experience as a practising orthopedist specialising in sports, spine, and regenerative medicine.  She has a Stanford affiliated Fellowship in Sports and Spine Medicine and a dual-Fellowship in Anti-Aging and Regenerative Medicine (FAARM) and Anti-Aging, Regenerative and Functional Medicine (FAARFM) through the American Academy of Anti-Aging Medicine (A4M). She also has a Fellowship in Human Potential and Epigenetic Medicine and is one of the first providers to receive the A4M National Peptide Certification. She also serves as a faculty member in the same organisation and the International peptide Society (IPS). You can connect with Dr Yurth through her Instagram and LinkedIn. Enjoyed This Podcast? If you did, be sure to subscribe and share it with your friends! Post a review and share it! If you enjoyed tuning in, then leave us a review. You can also share this with your family and friends so they can know how to optimise their immune system and fight disease more efficiently. Have any questions? You can contact me through email (support@lisatamati.com) or find me on Facebook, Twitter, Instagram and YouTube. For more episode updates, visit my website. You may also tune in on Apple Podcasts.   To pushing the limits, Lisa

Phil & Jake rank pop singer-songwriter Charli XCX, supervillain Doctor Doom, and the science of mycology on the List of Every Damn Thing.If you have something to add to the list, email it to list@everydamnthing.net (or get at us on Twitter, Instagram and Facebook). We also have a subreddit!SHOW NOTES: Phil said that Ludacris signed Justin Bieber but in reality Ludacris was just featured on Bieber's first single. Phil had Bieber confused with Chingy again. As Jake notes, Charli XCX is probably most known from songs where she's a featured guest. We discuss many of these, including “I Love It” by Icona Pop (feat. Charli XCX), “Fancy” by Iggy Azalea (feat. Charli XCX) and “Drop That Kitty” by Ty Dolla $ign (feat. Charli XCX & Tinashe). That last song is relevant to Phil because he lives with a cat now. Of course we also talk about some songs with Charli XCX as the main artist, including “Boom Clap”, “Break the Rules”, “Vroom Vroom”, “pink diamond”, “After the Afterparty” (feat. Lil Yachty), “1999” (with Troye Sivan) and “New Shapes” (feat. Christine and the Queens and Caroline Polachek). Jake thinks that last song sounds like the end of “Shock to Your System” by Tegan & Sara.  “Same Old Love” by Selena Gomez was written by Charli XCX, and as Phil notes sounds like “You Showed Me” by the Turtles. SOPHIE (RIP) was a producer who worked with Charli XCX. Jake and Phil agree that “Waterfalls” by TLC is one of the worst songs. WebMD says synesthesia is real. Here's a pretty good Doctor Doom reading list. It includes the following stories that we mention in this episode: Secret Wars (1984), Emperor Doom, Dr. Strange & Dr. Doom: Triumph and Torment and Secret Wars (2015). It's hard to talk about Doctor Doom without talking about the Marvel Comics' Fantastic Four, the title characters of “"The World's Greatest Comic Magazine!" Jake knew that a lame Doctor Doom was feature in the first two Fantastic Four movies from 20th Century Fox, but wasn't sure about the 2015 reboot. Research shows that Doom is, in fact, in it (but with the “Doctor” part of his name removed). Here's the pic of Doctor Doom with Sub-Mariner's horn that Phil refers to. Here's a bias-confirming article about Darth Vader borrowing from Doctor Doom. Voice of Latveria is a great podcast dedicated to all things Doom. Phil's not a Family Guy fan but he found this relevant clip while looking for Wile E. Coyote videos to show his dad. Phil ponders “Has there ever been a female Doom?” There seem to be women who dress up as Doom but without the mask which defeats the point. Watch Fantastic Fungi for a fun primer on mycology. ALSO DISCUSSED IN THIS EPISODE:imagination * Santa Claus * Britney Spears * PC Music * Lady Gaga * Harry Styles * Bon Jovi * Run the Jewels * Dan Aykroyd * Blade * the Romani * Doombots * Latveria * Bond films * Stan Lee & Jack Kirby * Large Marge * Magneto * Punisher skulls * Reed Richards * Cher * cats * Mendocino County * psilocybin * Quorn * mold * blue cheese * penicillin * metatextuality * The Matrix * firefightersBelow are the Top Ten and Bottom Top items on List of Every Damn Thing as of this episode (for the complete up-to-date list, go here).TOP TEN: Dolly Parton - person interspecies animal friends - idea sex - idea bicycles - tool coffee - beverage Clement Street in San Francisco - location Prince - person It's-It - food Doctor Doom - fictional character Cher - person BOTTOM TEN:226. Jon Voight - person227. Hank Williams, Jr - person228. British Royal Family - institution229. Steven Seagal - person230. McRib - food231. death - idea232. war - idea233. cigarettes - drug234. QAnon - idea235. transphobia - ideaTheme song by Jade Puget. Graphic design by Jason Mann. This episode was produced & edited by Jake MacLachlan. Show notes by Jake MacLachlan & Phil Green.Our website is everydamnthing.net and we're also on Twitter, Instagram and Facebook.Email us at list@everydamnthing.net. 

Alex Filstein is an award-winning inventor in Canada's energy sector whose innovations focus on emission-reducing technologies to achieve net zero greenhouse gas (GHG) emissions. Alex is the recipient of the 2018 Oilweek/JWN Magazine Rising Star Award and the recipient of the prestige 2019 Technical Achievement Alumni Award from University of Calgary Schulich School of Engineering. He lives in Calgary, Alberta, Canada, with his wife and two young sons who are both on the autistic spectrum. After his son's diagnosis, Alex was diagnosed ASD-Level 1 /Asperger's. He is an active volunteer in the autism community, administrator for the “Autism Stories ” group on Facebook and passionate about sharing data related to the autism community to advance happier Autism families. Connect with Alex on FB: @autismstories and @alexfilstein ***************************************** To purchase my book “Welcome to My Life – A Personal Parenting Journey Through Autism” click HERE or visit Amazon.com! You can easily stay connected to the Living the Sky Life podcast and me in various ways.  Please visit my website www.lauriehellmann.com for all the links. I'd love to hear what you think, so if listening on the Apple platform, please leave a written review and rating of the podcast!  If you are interested in being a guest on an episode of Living the Sky Life, please contact me!

As a former athlete, you may have a hard time finding a healthy relationship between your body and exercise. Many former athletes find that creating habits and routines after a long rest from working out feels like starting from scratch. With this, I believe that changing your mindset could be beneficial, especially when you're at the lowest point of your sports career or just in the transition of prioritizing other opportunities in your life. In this episode of the Live Your Personal Best podcast, I read the first chapter of my book Elite to Everyday Athlete: 9 Steps to Getting Off the Sidelines of Life titled The Never-Ending Off-Season. This chapter could help you find the workout routine that is perfect for you now that you're inactive in the sports arena and fit a healthy lifestyle with the other aspects of your life.  Listen to learn more about how you can make working out sustainable when you're no longer an athlete. Ready to read the full book?? https://amzn.to/3ysSbqW   Episode Timeline [2:15] Emily shares her struggle with her corporate job. [3:52] Emily brings up her problems when she stops her training and struggles to get back on track. [4:56] Emily stresses the value of rest in reaching one's goal. [6:35] Emily talks about finding a healthy balance between rest and exercise. [7:21] Emily introduces the dangers of too much rest. [8:20] Emily provides insights into the struggle of picking up a workout routine and balancing other opportunities after retirement. [10:41] Emily reveals the struggles of athletes when they realize that they have freedom of choice and how exercise is beneficial, especially during this phase of an athlete's life. [12:01] Emily cites the importance of slowing down to find the balance of rest and exercise. Key Takeaways Athletic retirement is an off-season without a return date. Rest is vital for elite athletes. Research shows no significant difference in exercise patterns between former athletes and non-athletes. Both are equally likely to become couch potatoes. Priorities change, and former athletes focus on finding a job, starting a family, or pursuing new opportunities. Former athletes should not ignore the value of exercise in their day-to-day life. Don't force yourself to a routine just because you think it's what it needs to happen. Balance prevents burnout. Exercise and rest are needed for different reasons. Exercise is known to improve your health, self-esteem, and support healthy sleep in addition to many other benefits. Rest aids in muscle recovery, reduces the risk of injury, and prevents fatigue. Both are equally important and will complement each other in giving you enough energy and strength to show up confidently in your daily activities. Quotes “When the things that motivate an athlete to train, medals, records, adrenaline, and competition aren't there in the real world. When an athlete trains at the top standard they have set for themselves, anything less feels just like that, less.” - Emily [5:37] “An athlete needs rest, but they also need a healthy relationship with exercise. This will help prevent them from burnout, or on the other side of the spectrum, inactivity.” - Emily [7:15] “Just because they are a star athlete and disciplined to wake up at 6 AM on Saturdays for four years doesn't mean this will translate into life afterward.” - Emily [8:11] Get your copy now: https://amzn.to/3ysSbqW  Learn more about your ad choices. Visit megaphone.fm/adchoices

On today's Manager Meeting, Greg Dowling interviews Florian Bartunek. Greg is the Co-CIO and Head of Research for Fund Evaluation Group, an institutional OCIO and investment consultant with $83 billion in assets under advisement. Florian is the founding partner and CIO of Constellation Asset Management, a long-only asset manager focused on Brazil with approximately $3 billion in AUM. Florian founded Constellation in 1999 alongside Jorge Paulo Lemann and 3G and brought in Steve Mandel's Lone Pine Capital as a partner in 2007. Their conversation starts with Florian's career in investment management, his passion for reading, and an overview of Brazil's business environment and equity market. They then turn to Constellation's investment philosophy, team, portfolio construction, and investment examples. Lastly, Florian discussed opportunities and risks in Brazil, and his prediction for Brazil in the next World Cup. Learn More Follow Ted on Twitter at @tseides or LinkedIn Subscribe to the mailing list Access Transcript with Premium Membership

On this episode of the Talent Magnet Institute Podcast Mike explores true leadership in light of the Great Resignation. He also discusses the Great Realization, and how leaders can use these principles to improve their leadership as well as create better environments for their employees. Mike posits that the Great Resignation is happening because of the Great Realization: people are taking stock of their lives and realizing that where they are is not where they wanted to be. They are changing jobs, and resigning because they're prioritizing their life goals, their families, and their careers. [2:39] If you influence people, you're a leader, and as a leader, people are watching how you respond to situations and problems. The pandemic has made this very clear, Mike says. The Great Realization has made us think critically about what we want to be doing, and who we want to be doing it with. We don't want to work with leaders who aren't responsive and proactive. [6:43] Mike talks about research papers on the Economic Drought from EMSI and The Global Workforce. Research has found that there are fewer people in the workforce now than years ago, and fewer people are looking for traditional full-time jobs. [8:10] Leaders nowadays - and especially in the future - need to be more compassionate, empathetic, and patient now. They also need to be more focused on their professional development. If you do not develop yourself as a leader, you cannot develop others. You need to recruit employees and build a pipeline, but most importantly, you need to create a culture where people want to work with you, and furthermore, stay with you. [13:55] Leadership is a privilege and leaders must view it as such. You have the opportunity to help others realize their full potential and become their best selves. Be proactive when it comes to talent development. Create an environment where employees are valued and supported, not one where everything is a competition. Create fair and inclusive environments that invite people to bring their whole selves to work. [16:55] Mike talks about the course on the Talent Magnet Institute's website that he created, that helps individuals better their leadership skills. [22:10] At the Talent Magnet Institute, the goal is to build employers who create organizations that encourage their employees to bring their authentic selves. [26:06] Mike's closing remarks are an encouragement to leaders to become more proactive, never give up, and make use of the tools and resources available out there to become the best leader they can be. [30:09] Resources Mike Sipple Jr. | LinkedIn | Twitter EMSI State of the Global Workplace Report The Leadership Basics

This week, Jeremy looks to the year ahead in ALS research with Dr. Kuldip Dave, Vice President of Research at The ALS Association, and digs into a drug rescue analysis project with Dr. Dave Ennist, CEO and Chief Science Officer at Origent Data Sciences.Learn more about The ALS Association's research program at https://www.als.org/researchTo get involved in ALS research go to https://www.als.org/research/how-can-i-get-involved-research-if-i-am-ineligible-clinicalThis episode is brought to you by The ALS Association in partnership with CitizenRacecar.

Each week on Counterpoint, we'll bring you a panel discussion with Canada's leading journalists, columnists, politicos, and change makers discussing what's happening in the newsphere. This week, we're joined by activist and former NDP candidate Shailene Panylo and National Post columnist Adam Zivo for a conversation on defunding the police and police abolition. About Shailene Panylo Shailene Panylo is a community organizer, activist, and advocate based in the Durham Region. She represented the NDP for Oshawa in 2019 and 2021. Shailene is a University of Toronto Alumni with an HBSc. in Molecular Biology, Immunology & Disease, and Women & Gender Studies and a TEFL instructor certified by the Ontario Institute of Studies in Education (OISE). Shailene currently works as the Research & Government Relations Coordinator for the Canadian Federation of Students National office and proudly serve as a Director and Coordinator for the Durham Black Students' Network. https://twitter.com/shailenepanylo?s=21 (Follow Shailene Panylo on Twitter) About Adam Zivo Adam Zivo is a regular columnist at the National Post, an activist having previously consulted with the Canadian Armed Forces on LGBTQ+ issues, and former Junior Research Fellow at the NATO Association of Canada focusing in the areas of cyber and information warfare and social media manipulation. https://twitter.com/zivoadam?s=21 (Follow Adam on Twitter) Stay connected with the latest from New Left Radio by https://newleft.us6.list-manage.com/subscribe?u=8227a4372fe8dc22bdbf0e3db&id=e99d6c70b4 (joining our mailing list) today! _________ Support this podcast

Bruminating Evil & The Final Stand with Vera Sharav Mark Twain once said that history doesn't repeat itself, but it does rhyme. That being said, do you, as someone who is an awakened mind see some distributing similarities between today and one of the darkest periods in world history? Our featured guest Vera Sharav is going to help us understand the past so we can be more aware of the present and have an idea of what to likely anticipate in the future. This could very well be humanity's last stand. A public advocate for human rights is the founder and president of the Alliance for Human Research Protection (AHRP) which serves as an information resource and public interest watchdog organization whose goal is to unlock the walls of secrecy in biomedical research and bring accountability to that endeavor. AHRP Infomails have a wide following: they are read by physicians and scientists, public health officials, journalists, lawyers, and patient advocacy organizations. Her advocacy achievements include: suspension of Environmental Protection Agency (EPA) pesticide experiment (CHEERS) on children; complaint led to two federal investigations on the use of children in foster care as guinea pigs in experimental AIDS drug and vaccine trials; suspension of smallpox vaccine on children; suspension of “violence prediction” experiment that exposed 6–11 year old NYC boys of color to fenfluramine ; opened a public debate about the ethics of relapse-inducing experiments in schizophrenia patients. Organized families and victims of unethical research to join her in testifying before the National Bioethics Advisory Committee (NBAC) — re: unethical experimentation on mentally disabled psychiatric patients; those testimonies led to a prize-winning series in the Boston Globe, “Doing Harm: Research on the Mentally Ill” — ultimately resulting in the shutdown of 29 clinical trials at the National Institute of Mental Health (1999). Mrs. Sharav served on the Children's Workgroup of the National Human Research Protection Advisory Committee where she was the sole dissenter objecting to expanded use of children in high risk medical experiments. She has testified before public policy advisory panels including, the Institute of Medicine — against human pesticide experiments; against prison drug research; numerous FDA hearings, against misuse of psychotropic drugs for children. She has been an invited presenter at various professional and academic forums: World Federation of Science Journalists, London; National Academy of Sciences Policy Fellow program and National Public Health Association re: screening for mental illness; Consumers Institute for Medicines and Health, Stockholm — re: America's overmedicated children; Columbia University; NY Hospital, Cornell; U.S. military medical ethics forum; University of Texas. Her recent peer-reviewed publications include: Screening for Mental Illness: The Merger of Eugenics and the Drug Industry, Ethical Human Psychology and Psychiatry (2005); Conflicts of Interest in Biomedical Research Harm Children With and Without Disabilities,” Journal of Disability Policy Studies (2004); “The Impact of FDAMA on the recruitment of children for research,” EHPP (2003); “Children in Clinical Research: A Conflict of Moral Values,” American Journal of Bioethics (2003); The ethics of conducting psychosis-inducing experiments,” Accountability in Research (1999). LINK: About the Alliance for Human Research Protection Our Mission The Alliance for Human Research Protection (AHRP) is a national network of lay people and professionals who are committed to upholding the humanitarian values and ethical standards of medicine enshrined in the Hippocratic Oath: “First, do no harm”; the Nuremberg Code (1947): “The Voluntary informed consent of the human subject is absolutely essential”; and the UNESCO Universal Declaration on Bioethics and Human Rights (2005): “Any preventive, diagnostic and therapeutic medical intervention is only to be carried out with the prior, free and informed consent of the person concerned, based on adequate information.” AHRP's mission is to ensure that the moral right of voluntary medical decision-making is upheld. To accomplish that mission, we engage in an educational campaign, providing relevant factual information including ethical, legal, technical reports, and media reports. We endeavor to counter widely disseminated false claims that exaggerate the benefits of medical interventions, while minimizing risks. Our educational efforts are directed at both professionals and the lay public, who may be unaware of a body of suppressed scientific evidence that refutes false promotional claims for drugs; including antidepressants, antipsychotics, statins; medical devices; and vaccinations, including those for Hepatitis B, HPV, and the flu. Our goal is to empower citizens with accurate information so that they can exercise their right to informed consent to medical research and medical procedures within clinical care. As a citizens' watchdog group, AHRP brings to public attention specific unethical violations of informed consent wherever they occur.

Glutathione deficiency is a common feature that complicates infections. We review new research linking suboptimal glutathione levels with increased disease severity and discuss how glutathione is related to vitamin D status as well as ways to support glutathione levels from a nutrition and lifestyle standpoint. Related: Save on MYOXCIENCE Nutrition's new Electrolyte Stix: https://bit.ly/electrolyte-stix *Buy one get one 50% OFF ends January 24th, 2022 Link to research: https://bit.ly/3tHZoVa Time Stamps: 0:06 Vitamin D and Glutathione levels appear to be related 0:42 Diseases linked with low glutathione levels 1:43 Glutathione is found in high concentrations in the liver 3:04 Mitochondria health depends on glutathione status 3:31 Exercise and Glutathione: very important for mitochondrial health 4:50 Fatty liver, mitochondrial dysfunction and glutathione 5:34 Fascinating paper about glutathione and Vitamin D you should read 6:00 This image tells the story quite well 8:00 Please share this video if you're digging it 8:46 New Electrolyte pre-sale 11:03 Glutathione and The C*19 virus 12:14 Low Glutathione even in young people who get infected 14:47 Glutathione impacts vitamin D binding and metabolism 17:42 Glutathione Testing: GGT and liver enzymes 18:33 GGT is a marker of environmental chemical exposure 19:46 Cysteine rich foods that can increase glutathione levels

In this week's podcast with the Pod Group's Sam Colley, CEO, and Felix Ontañón, Director of Research and Innovation, we discuss IoT connectivity and the Enterprise Network Operator (ENO) strategy. They share their insights on the IoT landscape, barriers to adoption, and information about their recent acquisition by G+D.The ENO strategy allows hardware manufacturing distributors, the companies creating the IoT projects, with the ability to be their own operator along with the benefits that come from it. Allowing companies to have more ownership and control over their project coupled with greater privacy.Sam Colley has focused his career on working in the telecommunications sector and the M2M/IoT communications market. He joined Pod Group in 2011 and contributed to the geographic and financial expansion of the company. Since 2019 he has been the CEO and focused on developing new global markets and increasing Pod's footprints in existing ones.Felix Ontañón is part of the Research and Innovation department at the Pod Group, where he works heavily in IoT connectivity and creating innovative technologies to overcome connectivity challenges. He is particularly interested in LPWANs, SIM card applets, eSIM/eUICC, Edge Computing, and Artificial Intelligence for IoT and has recently led Pod Group's Open Source Community initiatives.

Diane Furchtgott-Roth, adjunct professor of Economics at George Washington University, and former Deputy Assistant Secretary for Research and Technology at the U.S. Department of Transportation, Chief Economist at the U.S. Department of Labor, and Chief of Staff of the President's Council of Economic Advisers, joined WMAL's "O'Connor and Company" radio program on Wednesday about AT&T and Verizon agree to halt 5G rollout near airports. She breaks down what we should know about this telecom battle with airports and the FAA over 5G. For more coverage on the issues that matter to you, visit www.WMAL.com, download the WMAL app or tune in live on WMAL-FM 105.9 FM from 5-9 AM ET. To join the conversation, check us out on Twitter: @WMALDC, @LarryOConnor, @Jgunlock, @amber_athey and @patrickpinkfile. Show website: https://www.wmal.com/oconnor-company/ See omnystudio.com/listener for privacy information.

Challenging the dogma of gene evolution, and how chiral nanoparticles could give vaccines a boost.In this episode:00:45 Genome mutations may be less random than previously thoughtA long-standing doctrine in evolution is that mutations can arise anywhere in a genome with equal probability. However, new research is challenging this idea of randomness, showing that mutations in the genome of the plant Arabidosis thaliana appear to happen less frequently in important regions of the genome.Research article: Munroe et al.News and Views: Important genomic regions mutate less often than do other regions13:45 Research HighlightsHow hallucinogenic beer helped cement an ancient superpower's control, and a surprisingly enormous colony of breeding fish.Research Highlight: Drug-fuelled parties helped ancient Andean rulers to hold powerResearch Highlight: Vast fish breeding colony is more than twice the size of Paris16:11 How a left-handed nanoparticle could give vaccines a boostThe chirality of a molecule – whether it has a left- or right-handed orientation – can have significant impacts on how it works. This week, a team show that left-handed gold nanoparticles can stimulate the immune system of mice, and boost the activity of a flu vaccine.Research article: Xu et al.News and Views: Nanoparticle asymmetry shapes an immune response23:04 Briefing ChatWe discuss some highlights from the Nature Briefing. This time, Tasmanian devils' discerning diets break the rules on scavenging, and new techniques uncovering the sex of ancient human remains may rewrite our assumptions.Cosmos: Tasmanian devils puzzle science with picky eating habitsThe Observer: Archaeology's sexual revolutionSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday. See acast.com/privacy for privacy and opt-out information.

On this episode, we are joined by Dr. Amelia Furbish, PharmD (PhD candidate) and P4 USC College of Pharmacy student, Jordan Staires, to discuss various classes of psychoactive research pharmaceuticals. We review benzodiazepines, cathinones, tryptamines, phenethylamines, Kratom, benzedrex, phenibut, and more. While many medications in these classes have a promising future in clinical psychiatry, some are used recreationally. For that reason, we go over adverse effects, drug-drug interactions, and other aspects of their pharmacology that pharmacists and other healthcare providers should be familiar with.  Make sure to keep tabs on Dr. Furbish's journey to completing her medicinal chemistry PhD by following her Instagram page @happypillsrx Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

This podcast (also a video) answers questions from our listeners, viewers and newsletter subscribers, and updates you on our upcoming projects. Paul Merriman, founder and president of The Merriman Financial Education, is joined by Chris Pedersen, Director of Research and author of 2 Funds for Life — A quest for simple & effective investing strategies, and Daryl Bahls, Director of Analytics. Topics: What's on the trio's to-do list over the next few months? Chris will update the Best-In-Class recommendations. Daryl will update all of the important tables, including: Ultimate Buy and Hold, Fine Tuning Your Asset Allocation, Accumulation and Distributions and the No Nonsense portfolio tables. [Currently found at: https://paulmerriman.com/best-advice/]. Also, Paul will create a new presentation with a discussion of the "White Coat Investor" article, “150 Portfolios Better Than Yours.” Review of 2021 returns. How Chris selects the best ETFs. The two layers of unnecessary costs when hiring an advisor who recommends actively-managed funds. How to decide between an inexpensive index fund in a less-productive asset class and a more-expensive fund in a more-productive asset class. In this case, VSCIX (small cap index) and GSSIX (a small cap value fund). How to invest a $200,000 inherited IRA when the proceeds won't be used by the present owners in their lifetime. An investor asks if it's OK to invest in a group of asset-class funds that are not the same as the recommended portfolios on our website. Spoiler alert: Investor puts together a reasonable portfolio. How to invest a big hunk of money when the market looks like it is going to go down or should go down or might go down… who knows? Does Chris' evaluation include leveraged ETFs? Are they worth considering? What to do about large positions in a company that is your employer?

Tom Duncan, Head of Research and Investment Strategy for Cromwell Property Group joins Bold Founder Caleb Parker for the seventh episode of Season 6 to discuss Tom's recent publication in Insight Magazine, titled ‘Office 2025: The Next Evolutionary Cycle'. The two discuss how office demand is changing, thus creating a gap between supply & demand, and an abundance of misaligned stock, and what this means for commercial real estate investors. Tom shares how this moment in the market can seem scary, but that office evolution is nothing new, and we're now entering the age of Space-as-a-Service.  Caleb gives a shout out to Samantha McClary for her article on Bold in EG. Connect with Tom Duncan on LinkedIn https://www.linkedin.com/in/tom-duncan-ab9a6724/ Connect with Caleb Parker on LinkedIn  https://www.linkedin.com/in/calebparker/ If you have any questions or feedback on this episode, email podcast@workbold.co Value Bombs: When I read research papers from the real estate community it tends to be from a traditional mindset, but you've come across, dare I say ‘woke' in this. - Caleb I think up-close that the change that we're having at the moment in the market is quite scary for landlords and for investors... but if we zoom out onto a much longer time horizon, I think that gives us more balance that this is just the latest iteration of a constant process of invention and reinvention. - Tom We think what's happened in 2020 is the dawn of the age of Space-as-a-Service. - Tom In order to attract employees, I think offices must work harder and they must give them a better proposition. - Tom I think that we in commercial real estate have to stand up and be champions of this really good company culture and lead by example. - Caleb I just think we in commercial real estate have the opportunity to make such a positive impact on all the communities we go into. - Caleb Resources: TSK Documentary Insight Magazine ‘Offices 2025: The Next Evolutionary Cycle' Article Cromwell Property Group The Economist Magazine  The Economist Podcast MIPIM 2022, Cannes Shout Outs: James Goldsmith Antony Slumbers Dror Poleg  Samantha McClary About Our Guests: Tom Duncan https://www.linkedin.com/in/tom-duncan-ab9a6724/  https://twitter.com/tduncan_insight  Tom Duncan is the Head of Research and Investment Strategy for Cromwell Property Group. In his role, Tom is responsible for setting the research strategy for Cromwell's international platform. His team analyses market economic and thematic change to provide research and advice to the business, its clients and investors on investment opportunities. His advice supports the investment decision making process informs new fund launches and the allocation of capital expenditure with an existing mandate. Tom joined Cromwell in 2021, not long ago from Swiss Life Asset Managers, Europe's largest institutional owner of real estate, where he spent four years and was laterally director of strategy and innovation with research responsibility. Prior to that he spent two years at JLL in the UK as an Associate Director in the Corporate Research Team. Previously, he spent five years working in Australia at Hill PDA, an Economic Consultancy, and Colliers international as head of New South Wales and ACT research. Tom holds Master's degrees in property development from the UTS Sydney and Town and Country Planning from the University of Sheffield. About Our Host: Caleb Parker https://www.linkedin.com/in/calebparker/ Caleb Parker is an American entrepreneur in London, and Founder of Bold (acquired by Newable/NewFlex in 2019).He believes in "challenging the status quo" and is a champion for entrepreneurial and innovative thinking.Caleb has served as founder, Board member, advisor, investor and consultant to numerous startups and small businesses, and has a keen focus on innovation and technology, with interests in the MICE market, Space-as-a-Service, and the future of work.Caleb has been a guest lecturer, speaker, and moderator for topics such as entrepreneurship, the sharing economy, the future of work and commercial real estate at academic institutions and large corporations. He regularly takes the stage at numerous trade conferences as keynote speaker, MC, host or facilitator.Earlier in his career, Caleb was named one of Savannah, Georgia's “40 under 40” business leaders" in 2006 after launching two successful small businesses in the city's booming hospitality industry. A year later he moved to Washington, DC to join the The Regus Group DC management team. In 2009, Caleb co-founded a flexible workspace consulting firm where he brokered flexible workspace and advised businesses on agile working strategies.Caleb is one of the first licensed commercial real estate agents to speak on the flexible working trends and the rise of flexible workspace, and has been quoted in numerous publications. Timestamps [05:00] Tom gives a brief overview of Cromwell and the portfolio. Cromwell Property Group is an international investment manager with $8bn of assets split 50/50 between Europe and APAC. [06:00] What is the background on the research that led to the outcomes in the article ‘Office 2025: The Next Evolutionary Cycle'? The feature of the office was subject to such fierce debate in the industry and in the media more generally, they felt much of that debate was misinformed and subject to overly negative sentiment. Survey data shows that there are benefits for both employee and employer to utilising the office as a working environment.  Working patterns will change to accommodate office and home working, and where people end up working will be based on the tasks they need to complete.  There will be more incentivisation to get people back into the office. [11:00] Can you provide some context on the gap between supply and demand and where does Space-as-a-Service fit in? Employees and building occupiers now hold the power. Landlords should be viewing themselves as service providers to their customers, the occupiers, and this should lead to a physical evolution of the type of space that's provided.  [16:20] Your article quotes “[investors in real estate should] act with conviction to dispose of misalign stock and acquire product, which is, or can be aligned to future occupier demand”. Do Real Estate Investors not usually act with conviction? Real estate can be guilty of ‘herd mentality', meaning they follow the same patterns.  Acting with conviction might mean going against the grain or put themselves in an uncomfortable position based on the narrative at the time.  [18:40] What's your view on building from the ground up versus buying and repurpose? Much of the existing stock will need to be repositioned to make sure that it aligns with what occupiers of today want and occupies as tomorrow as well. Environmental factors mean it will be increasingly difficult to create new buildings from scratch, so repurposing an existing building will be much more environmentally friendly.  [23:30] How does Cromwell look at rolling out Space-as-a-Service across the portfolio? A tailored approach depending on offices, locations and market need.    [24:50] Quickfire round questions. Tom's go to for workplace insight are Antony Slumbers, Dror Poleg, The Economist Magazine and Podcast Tom would like to use a magic wand to see us valuing environmental factors far more highly in real estate. Tom's favourite holiday destination is Brisbane, Australia.  Sponsors Headline Sponsor: TSK TSK creates inspiring workplaces for some of the world's biggest brands across the UK and Ireland, They've been working for 25 years to deliver the best employee experiences and the vision of their clients. Not only do they create great places to work, TSK share workplace content every week from the latest data to inspiring spaces they've designed and built. You can read their latest insights at www.tskgroup.co.uk or check out their LinkedIn and Instagram pages to become a follower, fan and friend. Fortune Favours the Bold Bold merges property management & Space-as-a-Service to drive asset value and help office customers grow faster. Now part of NewFlex (www.workbold.co)  Future Proof Your Portfolio with NewFlex NewFlex delivers and manages a range of branded solutions for every type of building, in every type of location, for every type of occupier. Including the flexibility to develop your own brand. All enabled by flexible management contracts where we are invested in making money for you. (www.newflex.com) Launch Your Own Podcast Kopus.com is the leading podcast production and strategic content company for brands, organisations, institutions, individuals, and entrepreneurs. Our team sets you up with the right strategy, equipment, training, and guidance and content to ensure you sound amazing while speaking to your niche audience and networking with your perfect clients. Get in touch jason@kopus.com Subscribe to the #WorkBold Podcast https://www.linkedin.com/newsletters/workbold-podcast-6868874680095277056/

This podcast (also a video) answers questions from our listeners, viewers and newsletter subscribers, and updates you on our upcoming projects. Paul Merriman, founder and president of The Merriman Financial Education, is joined by Chris Pedersen, Director of Research and author of 2 Funds for Life — A quest for simple & effective investing strategies, and Daryl Bahls, Director of Analytics. Topics: What's on the trio's to-do […] The post Your questions answered, our plans revealed appeared first on Paul Merriman.

About ShirShir Tamari is the Head of Research of Wiz, the cloud security company. He is an experienced security and technology researcher specializing in vulnerability research and practical hacking. In the past, he served as a consultant to a variety of security companies in the fields of research, development and product.About SagiSagi Tzadik is a security researcher in the Wiz Research Team. Sagi specializes in research and exploitation of web applications vulnerabilities, as well as network security and protocols. He is also a Game-Hacking and Reverse-Engineering enthusiast.About NirNir Ohfeld is a security researcher from Israel. Nir currently does cloud-related security research at Wiz. Nir specializes in the exploitation of web applications, application security and in finding vulnerabilities in complex high-level systems.Links: Wiz: https://www.wiz.io Cloud CVE Slack channel: https://cloud-cve-db.slack.com/join/shared_invite/zt-y38smqmo-V~d4hEr_stQErVCNx1OkMA Wiz Blog: https://wiz.io/blog Twitter: https://twitter.com/wiz_io TranscriptAnnouncer: Hello, and welcome to Screaming in the Cloud with your host, Chief Cloud Economist at The Duckbill Group, Corey Quinn. This weekly show features conversations with people doing interesting work in the world of cloud, thoughtful commentary on the state of the technical world, and ridiculous titles for which Corey refuses to apologize. This is Screaming in the Cloud.Corey: This episode is sponsored in part by our friends at Redis, the company behind the incredibly popular open source database that is not the bind DNS server. If you're tired of managing open source Redis on your own, or you're using one of the vanilla cloud caching services, these folks have you covered with the go to manage Redis service for global caching and primary database capabilities; Redis Enterprise. To learn more and deploy not only a cache but a single operational data platform for one Redis experience, visit redis.com/hero. Thats r-e-d-i-s.com/hero. And my thanks to my friends at Redis for sponsoring my ridiculous non-sense.  Corey: This episode is sponsored in part by our friends at Rising Cloud, which I hadn't heard of before, but they're doing something vaguely interesting here. They are using AI, which is usually where my eyes glaze over and I lose attention, but they're using it to help developers be more efficient by reducing repetitive tasks. So, the idea being that you can run stateless things without having to worry about scaling, placement, et cetera, and the rest. They claim significant cost savings, and they're able to wind up taking what you're running as it is in AWS with no changes, and run it inside of their data centers that span multiple regions. I'm somewhat skeptical, but their customers seem to really like them, so that's one of those areas where I really have a hard time being too snarky about it because when you solve a customer's problem and they get out there in public and say, “We're solving a problem,” it's very hard to snark about that. Multus Medical, Construx.ai and Stax have seen significant results by using them. And it's worth exploring. So, if you're looking for a smarter, faster, cheaper alternative to EC2, Lambda, or batch, consider checking them out. Visit risingcloud.com/benefits. That's risingcloud.com/benefits, and be sure to tell them that I said you because watching people wince when you mention my name is one of the guilty pleasures of listening to this podcast.Corey: Welcome to Screaming in the Cloud, I'm Corey Quinn. One of the joyful parts of working with cloud computing is that you get to put a whole lot of things you don't want to deal with onto the shoulders of the cloud provider you're doing business with—or cloud providers as the case may be, if you fallen down the multi-cloud well. One of those things is often significant aspects of security. And that's great, right, until it isn't. Today, I'm joined by not one guest, but rather three coming to us from Wiz, which I originally started off believing was, oh, it's a small cybersecurity research group. But they're far more than that. Thank you for joining me, and could you please introduce yourself?Shir: Yes, thank you, Corey. My name is Shir, Shir Tamari. I lead the security research team at Wiz. I working in the company for the past year. I'm working with these two nice teammates.Nir: Hi, my name is Nir Ohfield,. I'm a security researcher at the Wiz research team. I've also been working for the Wiz research team for the last year. And yeah.Sagi: I'm Sagi, Sagi Tzadik. I also work for the Wiz research team for the last six months.Corey: I want to thank you for joining me. You folks really burst onto the scene earlier this year, when I suddenly started seeing your name come up an awful lot. And it brought me back to my childhood where there was an electronics store called Nobody Beats the Wiz. It was more or less a version of Fry's on a different coast, and they went out of business and oh, good. We're going back in time. And suddenly it felt like I was going back in time in a different light because you had a number of high profile vulnerabilities that you had discovered, specifically in the realm of Microsoft Azure. The two that leap to mind the most readily for me are ChaosDB and the OMIGOD exploits. There was a third as well, but why don't you tell me, in your own words, what it is that you discovered and how that played out?Shir: We, sort of, found the vulnerabilities in Microsoft Azure. We did report multiple vulnerabilities also in GCP, and AWS. We had multiple vulnerabilities in AWS [unintelligible 00:02:42] cross-account. It was a cross-account access to other tenants; it just was much less severe than the ChaosDB vulnerability that we will speak on more later. And a both we've present in Blackhat in Vegas in [unintelligible 00:02:56]. So, we do a lot of research. You mentioned that we have a third one. Which one did you refer to?Corey: That's a good question because you had the I want to say it was called as Azurescape, and you're doing a fantastic job with branding a number of your different vulnerabilities, but there's also, once you started reporting this, a lot of other research started coming out as well from other folks. And I confess, a lot of it sort of flowed together and been very hard to disambiguate, is this a systemic problem; is this, effectively, a whole bunch of people piling on now that their attention is being drawn somewhere; or something else? Because you've come out with an awful lot of research in a short period of time.Shir: Yeah, we had a lot of good research in the past year. It's a [unintelligible 00:03:36] mention Azurecape was actually found by a very good researcher in Palo Also. And… do you remember his name?Sagi: No, I can't recall his name is.Corey: Yeah, they came out of unit 42 as I recall, their cybersecurity division. Every tech company out there seems to have some sort of security research division these days. What I think is, sort of, interesting is that to my understanding, you were founded, first and foremost, as a security company. You're not doing this as an ancillary to selling something else like a firewall, or, effectively, you're an ad comp—an ad tech company like Google, we you're launching Project Zero. You are first and foremost aimed at this type of problem.Shir: Yes. Wiz is not just a small research company. It's actually pretty big company with over 200 employees. And the purpose of this product is a cloud security suite that provides [unintelligible 00:04:26] scanning capabilities in order to find risks in cloud environments. And the research team is a very small group. We are [unintelligible 00:04:35] researchers.We have multiple responsibilities. Our first responsibility is to find risks in cloud environments: It could be misconfigurations, it could be vulnerabilities in libraries, in software, and we add those findings and the patterns we discover to the product in order to protect our customers, and to allow them for new risks. Our second responsibility is also to do a community research where we research everyone vulnerabilities in public products and cloud providers, and we share our findings with the cloud providers, then also with the community to make the cloud more secure.Corey: I can't shake the feeling that if there weren't folks doing this sort of research and shining a light on what it is that the cloud providers are doing, if they were to discover these things at all, they would very quietly, effectively, fix it in the background and never breathe a word of it in public. I like the approach that you're taking as far as dragging it, kicking and screaming, into the daylight, but I also have to imagine that probably doesn't win you a whole lot of friends at the company that you're focusing on at any given point in time. Because whenever you talk to a company about a security issue, it seems like the first thing they're concerned about is, “Okay, how do we wind up spinning this or making sure that we minimize the reputational damage?” And then there's a secondary reaction of, “Oh, and how do we protect our customers? But mostly, how do we avoid looking bad as a result?” And I feel like that's an artifact of corporate culture these days. But it feels like the relationship has got to be somewhat interesting to navigate from your perspective.Shir: So, once we found a vulnerability and we discuss it with the vendor, okay, first, I will mention that most cloud providers have a bug bounty program where they encourage researchers to find vulnerabilities and to discover new security threats. And all of them, as a public disclosure, [unintelligible 00:06:29] program will researchers are welcome and get safe harbor, you know, where the disclosure vulnerabilities. And I think it's, like, common interest, both for customers, but for researchers, and the cloud providers to know about those vulnerabilities, to mitigate it down. And we do believe that sometimes cloud providors does resolve and mitigate vulnerabilities behind the scenes, and we know—we don't know for sure, but—I don't know about everything, but just by the vulnerabilities that we find, we assume that there is much more of them that we never heard about. And this is something that we believe needs to be changed in the industry.Cloud providers should be more transparent, they should show more information about the result vulnerabilities. Definitely when a customer data was accessible, or where it was at risk, or at possible risk. And this is actually—it's something that we actually trying to change in the industry. We have a community and, like, innovative community. It's like an initiative that we try to collect, we opened a Slack channel called the Cloud CVE, and we try to invite as much people as we can that concern about cloud's vulnerabilities, in order to make a change in the industry, and to assist cloud providers, or to convince cloud providers to be more transparent, to enumerate cloud vulnerabilities so they have an identifier just, like cloud CVE, like a CVE, and to make the cloud more protected and more transparent customers.Corey: The thing that really took me aback by so much of what you found is that we've become relatively accustomed to a few patterns over the past 15 to 20 years. For example, we're used to, “Oh, this piece of software you run on your desktop has a horrible flaw. Great.” Or this thing you run in your data center, same story; patch, patch, patch, patch patch. That's great.But there was always the sense that these were the sorts of things that were sort of normal, but the cloud providers were on top of things, where they were effectively living up to their side of the shared responsibility bargain. And that whenever you wound up getting breached, for whatever reason—like in the AWS world, where oh, you wound up losing a bunch of customer data because you had an open S3 bucket? Well, yeah, that's not really something you can hang super effectively around the neck of the cloud provider, given that you're the one that misconfigured that. But what was so striking about what you found with both of the vulnerabilities that we're talking about today, the customer could have done everything absolutely correctly from the beginning and still had their data exposed. And that feels like it's something relatively new in the world of cloud service providers.Is this something that's been going on for a while and we're just now shining a light on it? Have I just missed a bunch of interesting news stories where the clouds have—“Oh, yeah, by the way, people, we periodically have to go in and drag people out of our cloud control plane because oops-a-doozy, someone got in there again with the squirrels,” or is this something that is new?Shir: So, we do see an history other cases where probability [unintelligible 00:09:31] has disclosed vulnerabilities in the cloud infrastructure itself. There was only few, and usually, it was—the research was conducted by independent researchers. And I don't think it had such an impact, like ChaosDB, which allowed [cross-system 00:09:51] access to databases of other customers, which was a huge case. And so if it wasn't a big story, so most people will not hear about it. And also, independent researchers usually don't have the back that we have here in Wiz.We have a funding, we have the marketing division that help us to get coverage with reporters, who make sure to make—if it's a big story, we make sure that other people will hear about it. And I believe that in most bug bounty programs where independent researchers find vulnerabilities, usually they more care about the bounty than the aftereffect of stopping the vulnerability, sharing it with the community. Usually also, independent [unintelligible 00:10:32] usually share the findings with the research community. And the research community is relatively small to the IT community. So, it is new, but it's not that new.There was some events back in history, [unintelligible 00:10:46] similar vulnerabilities. So, I think that one of the points here is that everyone makes a mistake. You can find bugs which affected mostly, as you mentioned previously, this software that you installed on your desktop has bugs and you need to patch it, but in the case of cloud providers, when they make mistakes, when they introduce bugs to the service, it affects all of their customers. And this is something that we should think about. So, mistakes that are being made by cloud providers have a lot of impact regarding their customers.Corey: Yeah. It's not a story of you misconfigured, your company's SAN, so you're the one that was responsible for a data breach. It's suddenly, you're misconfiguring everyone's SAN simultaneously. It's the sheer scale and scope of what it is that they've done. And—Shir: Yeah, exactly.Corey: —I'm definitely on board with that. But the stuff I've seen in the past, from cloud providers—AWS, primarily, since that is admittedly where I tend to focus most of my time and energy—has been privilege escalation style stuff, where, okay, if you assign some users at your company—or wherever—access to this managed IAM policy, well, they'll have suddenly have access to things that go beyond the scope of that. And that's not good, let's be very clear on that, but it is a bit different between that and oh, by the way, suddenly, someone in another company that has no relationship established with you at all can suddenly rummage through your data that you're storing in Cosmos DB, their managed database offering. That's the thing to me that I think was the big head-turning aspect of this, not just for me, but for a number of folks I've spoken to, in financial services, in government, in a bunch of environments where data privacy is not optional in the same way that it is when, you know, you're running a social media for pets app.Nir: [laugh]. Yeah, but the thing is, that until the publication of ChaosDB, no one ever heard about the [unintelligible 00:12:40] data tampering in any cloud providers. Meaning maybe in six months, you can see a similar vulnerabilities in other cloud providers that maybe other security research groups find. So yeah, so Azure was maybe the first, but we don't think they will be the last.Shir: Yes. And also, when we do the community research, it is very important to us to take big targets. We enjoy the research. One day, the research will be challenging and we want to do something that it was new and great, so we always put a very big targets. To actually find vulnerability in the infrastructure of the cloud provider, it was very challenging for us.When didn't came ChaosDB by that; we actually found it by mistake. But now we think actively that this is our next goal is to find vulnerabilities in the infrastructure and not just vulnerabilities that affect only the—vulnerabilities within the account itself, like [unintelligible 00:13:32] or bad scoped policies that affects only one account.Corey: That seems to be the transformative angle that you don't see nearly as much in existing studies around vulnerabilities in this space. It's always the, “Oh, no. We could have gotten breached by those people across the hallway from us in our company,” as opposed to folks on the other side of the planet. And that is, I guess, sort of the scary thing. What has also been interesting to me, and you obviously have more experience with this than I do, but I have a hard time envisioning that, for example, AWS, having a vulnerability like this and not immediately swinging into disaster firefighting mode, sending their security execs on a six month speaking tour to explain what happened, how it got there, all of the steps that they're taking to remediate this, but Azure published a blog post explaining this in relatively minor detail: Here are the mitigations you need to take, and as far as I can tell, then they sort of washed their hands of the whole thing and have enthusiastically begun saying absolutely nothing since.And that I have learned is sort of fairly typical for Microsoft, and has been for a while, where they just don't talk about these things when it arises. Does that match your experience? Is this something that you find that is common when a large company winds up being, effectively, embarrassed about their security architecture, or is this something that is unique to Microsoft tends to approach these things?Shir: I would say in general, we really like the Microsoft MSRC team. The group in Microsoft that's responsible for handling vulnerabilities, and I think it's like the security division inside Microsoft, MSRC. So, we have a really good relationship and we had really good time working with them. They're real professionals, they take our findings very seriously. I can tell that in the ChaosDB incident, they didn't plan to publish a blog post, and they did that after the story got a lot of attention.So, I'm looking at a PR team, and I have no idea out there decide stuff and what is their strategy, but as I mentioned earlier, we believe that there is much more cloud vulnerabilities that we never heard of, and it should change; they should publish more.Nir: It's also worth mentioning that Microsoft acted really quick on this vulnerability and took it very seriously. They issued the fix in less than 48 hours. They were very transparent in the entire procedure, and we had multiple teams meeting with them. The entire experience was pretty positive with each of the vulnerability we've ever reported to Microsoft.Sagi: So, it's really nice working with the guys that are responsible for security, but regarding PR, I agree that they should have posted more information regarding this incident.Corey: The thing that I found interesting about this, and I've seen aspects of it before, but never this strongly is, I was watching for, I guess, what I would call just general shittiness, for lack of a better term, from the other providers doing a happy dance of, “Aha, we're better than you are,” and I saw none of that. Because when I started talking to people in some depth at this at other companies, the immediate response—not just AWS, to be clear—has been no, no, you have to understand, this is not good for anyone because this effectively winds up giving fuel to the slow-burning fire of folks who are pulling the, “See, I told you the cloud wasn't secure.” And now the enterprise groundhog sees that shadow and we get six more years of building data centers instead of going to the cloud. So, there's no one in the cloud space who's happy with this kind of revelation and this type of vulnerability. My question for you is given that you are security researchers, which means you are generally cynical and pessimistic about almost everything technological, if you're like most of the folks in that space that I've spent time with, is going with cloud the wrong answer? Should people be building their own data centers out? Should they continue to be going on this full cloud direction? I mean, what can they do if everything's on fire and terrible all the time?Shir: So, I think that there is a trade-off when you embrace the cloud. On one hand, you get the fastest deployment times, and a good scalability regarding your infrastructure, but on the other end, when there is a security vulnerability in the cloud provider, you are immediately affected. But it is worth mentioning that the security teams or the cloud providers are doing extremely good job. Most likely, they are going to patch the vulnerability faster than it would have been patched in on-premise environment. And it's good that you have them working for you.And once the vulnerability is mitigated—depends on the vulnerability but in the case of ChaosDB—when the vulnerability was mitigated on Microsoft's end, and it was mitigated completely. No one else could have exploited after the mitigated it once. Yes, it's also good to mention that the cloud provides organization and companies a lot of security features, [unintelligible 00:18:34] I want to say security features, I would say, it provides a lot of tooling that helps security. The option to have one interface, like one API to control all of my devices, to get visibility to all of my servers, to enforce policies very easily, it's much more secure than on-premise environments, where there is usually a big mess, a lot of vendors.Because the power was in the on-prem, the power was on the user, so the user had a lot of options. Usually used many types of software, many types of hardware, it's really hard to mitigate the software vulnerability in on-prem environments. It's really helped to get the visibility. And the cloud provides a lot of security, like, a good aspects, and in my opinion, moving to the cloud for most organization would be a more secure choice than remain on-premise, unless you have a very, very small on-prem environment.Corey: This episode is sponsored by our friends at Oracle HeatWave is a new high-performance accelerator for the Oracle MySQL Database Service. Although I insist on calling it “my squirrel.” While MySQL has long been the worlds most popular open source database, shifting from transacting to analytics required way too much overhead and, ya know, work. With HeatWave you can run your OLTP and OLAP, don't ask me to ever say those acronyms again, workloads directly from your MySQL database and eliminate the time consuming data movement and integration work, while also performing 1100X faster than Amazon Aurora, and 2.5X faster than Amazon Redshift, at a third of the cost. My thanks again to Oracle Cloud for sponsoring this ridiculous nonsense.Corey: The challenge I keep running into is that—and this is sort of probably the worst of all possible reasons to go with cloud, but let's face it, when us-east-1 recently took an outage and basically broke a decent swath of the internet, a lot of companies were impacted, but they didn't see their names in the headlines; it was all about Amazon's outage. There's a certain value when a cloud provider takes an outage or a security breach, that the headlines screaming about it are about the provider, not about you and your company as a customer of that provider. Is that something that you're seeing manifest across the industry? Is that an unhealthy way to think about it? Because it feels almost like it's cheating in a way. It's, “Yeah, we had a security problem, but so did the entire internet, so it's okay.”Nir: So, I think that if there would be evidence that these kind of vulnerabilities were exploited while disclosure, then you wouldn't see headlines of companies, shouting in the headlines. But in the case of the us reporting the vulnerabilities prior to anyone exploiting them, results in nowhere a company showing up in the headlines. I think it's a slightly different situation than an outage.Shir: Yeah, but also, when one big provider have an outage or a breach, so usually, the customers will think it's out of my responsibility. I mean, it's bad; my data has been leaked, but what can I do? I think it's very easy for most people to forgive companies [unintelligible 00:21:11]. I mean, you know what, it's just not my area. So, maybe I'm not answer that into that. [laugh].Corey: No, no, it's very fair. The challenge I have, as a customer of all of these providers, to be honest, is that a lot of the ways that the breach investigations are worded of, “We have seen no evidence that this has been exploited.” Okay, that simultaneously covers the two very different use cases of, “We have pored through our exhaustive audit logs and validated that no one has done this particular thing in this particular way,” but it also covers the use case, “Of, hey, we learned we should probably be logging things, but we have no evidence that anything was exploited.” Having worked with these providers at scale, my gut impression is that they do in fact, have fairly detailed logs of who's doing what and where. Would you agree with that assessment, or do you find that you tend to encounter logging and analysis gaps as you find these exploits?Shir: We don't really know. Usually when—I mean, ChaosDB scenario, we got access to a Jupyter Notebook. And from the Jupyter Notebook, we continued to another internal services. And we—nobody stopped us. Nobody—we expected an email, like—Corey: “Whatcha doing over there, buddy?”Shir: Yeah. “Please stop doing that, and we're investigating you.” And we didn't get any. And also, we don't really know if they monitor it or not. I can tell from my technical background that logging so many environments, it's hard.And when you do decide to log all these events, you need to decide what to log. For example, if I have a database, a managed database, do I log all the queries that customers run? It's too much. If I have an HTTP application—a managed HTTP application—do I save all the access logs, like all the requests? And if so, what will be the retention time? For how long?We believe that it's very challenging on the cloud provider side, but it just an assumption. And doing the discussion with Microsoft, the didn't disclose any, like, scenarios they had with logging. They do mention that they're [unintelligible 00:23:26] viewing the logs and searching to see if someone exploited this vulnerability before we disclosed it. Maybe someone discovered before we did. But they told us they didn't find anything.Corey: One last area I'd love to discuss with you before we call it an episode is that it's easy to view Wiz through the lens of, “Oh, we just go out and find vulnerabilities here and there, and we make companies feel embarrassed—rightfully so—for the things that they do.” But a little digging shows that you've been around for a little over a year as a publicly known entity, and during that time, you've raised $600 million in funding, which is basically like what in the world is your pitch deck where you show up to investors and your slides are just, like, copies of their emails, and you read them to them?[laugh]I mean, on some level, it seems like that is a… as-, astounding amount of money to raise in a short period of time. But I've also done a little bit of digging, and to be clear, I do not believe that you have an extortion-based business model, which is a good thing. You're building something very interesting that does in-depth analysis of cloud workloads, and I think it's got an awful lot of promise. How does the vulnerability research that you do tie into that larger platform, other than, let's be honest, some spectacularly effective marketing.Sagi: Specifically in the ChaosDB vulnerability, we were actually not looking for a vulnerability in the cloud service providers. We were originally looking for common misconfigurations that our customers can make when they set up their Cosmos DB accounts, so that our product will be able to alert our customers regarding such misconfigurations. And then we went to the Azure portal and started to enable all of the features that Cosmos DB has to offer, and when we enabled enough features, we noticed some feature that could be vulnerable, and we started digging into it. And we ended up finding ChaosDB.But our original work was to try and find misconfigurations that our customers can make in order to protect them and not to find a vulnerability in the [CSP 00:25:31]. This was just, like, a byproduct of this research.Shir: Yes. There is, as I mentioned earlier, our main responsibility is to add a little security rist content to the product, to help customers to find new security risks in their environment. As you mentioned, like, the escalation possibilities within cloud accounts, and bad scoped policies, and many other security risks that are in the cloud area. And also, we are a very small team inside a big company, so most of the company, they are doing heavy [unintelligible 00:26:06] and talk with customers, they understand the risks, they understand the market, what the needs for tomorrow, and maybe we are well known for our vulnerabilities, but it just a very small part of the company.Corey: On some level, it says wonderful things about your product, and also terrifying things from different perspectives of, “Oh, yeah, we found one of the worst cloud breaches in years by accident,” as opposed to actively going in trying to find the thing that has basically put you on the global map of awareness around these things. Because there a lot of security companies out there doing different things. In fact, go to RSA, and you'll see basically 12 companies that just repeated over and over and over with different names and different brandings, and they're all selling some kind of firewall. This is something actively different because everyone can tell beautiful pictures with slides and whatnot, and the corporate buzzwords. You're one of those companies that actually did something meaningful, and it felt almost like a proof of concept. On some level, the fact that you weren't actively looking for it is kind of an amazing testament for the product itself.Shir: Yeah. We actually used the product in the beginning, in order to overview our own environment, and what is the most common services we use. In order—and we usually we mix this information with our product managers, know to understand what customers use and what products and services we need to research in order to bring value to the product.Sagi: Yeah, so the reason we chose to research Cosmos DB was that, we found that a lot of our Azure customers are using Cosmos DB on their production environments, and we wanted to add mitigations for common misconfigurations to our product in order to protect our customers.Nir: Yeah, the same goes with our other research, like OMIGOD, where we've seen that there is a excessive amount of [unintelligible 00:27:56] installations in an Azure environment, and it raised our [laugh] it raised our attention, and then found this vulnerability. It's mostly, like, popularity-guided research. [laugh].Shir: Yeah. And also [unintelligible 00:28:11] mention that maybe we find vulnerabilities by accident, but the service, we are doing vulnerability itself for the past ten years, and even more. So, we are very professional and this is what we do, and this is what we like to do. And we came skilled to the [crosstalk 00:28:25].Corey: It really is neat to see, just because every other security tool that I've looked at in recent memory tells you the same stuff. It's the same problem you see in the AWS billing space that I live in. Everyone says, “Oh, we can find these inactive instances that could be right-sized.” Great, because everyone's dealing with the same data. It's the security stuff is no different. “Hey, this S3 bucket is open.” Yes, it's a public web server. Please stop waking me up at two in the morning about it. It's there by design.But it goes back and forth with the same stuff just presented differently. This is one of the first truly novel things I've seen in ages. If nothing else, you convince me to kick the tires on it, and see what kind of horrifying things I can learn about my own environments with it.Shir: Yeah, you should. [laugh]. Let's poke [unintelligible 00:29:13].[laugh].Corey: I want to thank you so much for taking the time to speak with me today. If people want to learn more about the research you're up to and the things that you find interesting, where can they find you all?Shir: Most of our publication—I mean, all of our publications are under the Wiz, which is wiz.io/blog, and people can read all of our research. Just today we are announcing a new one, so feel free to go and read there. And they also feel free to approach us on Twitter, the service, we have a Twitter account. We are open for, like, messages. Just send us a message.Corey: And we will certainly put links to all of that in the [show notes 00:29:49]. Shir, Sagi, Nir, thank you so much for joining me today. I really appreciate your time.Shir: Thank you.Sagi: Thank you.Nir: Thank you much.Shir: It was very fun. Yeah.Corey: This has been Screaming in the Cloud. I'm Cloud Economist Corey Quinn and thank you for listening. If you've enjoyed this podcast, please leave a five-star review on your podcast platform of choice, whereas if you've hated this podcast, please leave a five-star review on your podcast platform of choice along with an angry insulting comment from someone else's account.Corey: If your AWS bill keeps rising and your blood pressure is doing the same, then you need The Duckbill Group. We help companies fix their AWS bill by making it smaller and less horrifying. The Duckbill Group works for you, not AWS. We tailor recommendations to your business and we get to the point. Visit duckbillgroup.com to get started.Announcer: This has been a HumblePod production. Stay humble.

This week, Maria is talking about caregiving, grief and dating with Brooke James and Katie Brandt.Brooke James is a highly respected podcaster in the field of grief and loss based in New York City. She is a sought-out grief educator who consults with companies and organizations seeking to create empathetic and supportive work environments, particularly during this time of unprecedented loss. She currently works at Aidaly, a startup focused on paying family caregivers, and previously worked in management consulting. Brooke holds a B.A. in Economics from The George Washington University. Brooke is passionate about arts and public programming in New York. She serves on the Steering Committee of the Lincoln Center Young Patrons as co-chair of the Development Committee. As one of the many people that have been affected by cancer, Brooke is highly involved in fundraising for the advancement of cancer research and treatment. Brooke participates in Memorial Sloan Kettering's fundraiser for rare cancer research and has raised over $25,000 since 2018.Follow Brook on Instagram:http://instagram.com/brookeljames http://instagram.com/the_griefcoachLearn more about Brook at http://thegriefcoach.coKatie Brandt is the Director of Caregiver Support Services and Public Relations in the Frontotemporal Disorders (FTD) Unit at Massachusetts General Hospital. Katie provides leadership for research, education and community events aimed at supporting the caregiver experience for families impacted by Alzheimer's Disease, Frontotemporal Disorders, atypical and young-onset dementias. Katie was Co-Chair of the National Alzheimer's Project Act (NAPA) Advisory Council on Alzheimer's Research, Care and Services (2019 – 2021) where she had the opportunity to connect with experts in the field of Alzheimer's Disease and related dementias and contribute to federal policy initiatives and research priorities promoting health equity and person-centered care at every stage of dementia. Katie is a passionate advocate in the rare disease and dementia community, inspired by her experience as a former FTD caregiver for her late husband, Mike. Today, Katie is an Alzheimer's caregiver for her father, Tom. Her experiences of love and loss embolden her to keep moving forward, determined that the cure of tomorrow is not so far from the care of today.Learn more about Katie at http://KatieBrandt.orgFollow Maria on Instagram to find out when the Matchmaker Hotline will be open to talk! http://instagram.com/matchmakermaria Follow Agape Match on Instagram at http://instagram.com/agapematchFollow the podcast on Instagram at http://instagram.com/askamatchmaker

We often waiver between calling this organization the TMZ of politics and the Deux Moi of Politics, but either way OpenSecrets brings the tea. Piping hot in fact, because in the world of politics it's all about that money honey. Some may follow the yellow brick road, but OpenSecrets follows the money, seeing which politicians are funded by who, what companies are throwing their dollars to the dark side and more. Cue this interview with Sarah Bryner, Director of Research & Strategy at OpenSecrets who gives us the scoop on how it all works, what OpenSecrets does, and its impact. This convo had us loving OpenSecrets even more than we already did and we can't recommend diving in feet first more. Donate to Girl and the Gov!https://www.paypal.com/paypalme/girlandthegovNew Website & Internship Description:https://www.girlandthegov.com/careersInternship Description:https://www.girlandthegov.com/careersCitizen Power with Nathalia Ramos & Ben Sheehan:https://www.onecommune.com/a/2147492814/nBoX9mJoPrima:https://www.prima.co/ Use code GIRLGOV for 20% offBrand Ambassador Program:https://www.girlandthegov.com/the-ambassadors

Dr. Carl Telford is the Research and Innovation Manager at Consortium for Battery Innovation, where he facilitates funding opportunities for lead batteries across multiple applications and sectors.

Links:Visit Lux Research's WebsiteEmail: laura.krishfield@luxresearchinc.comConnect with Laura on LinkedIn!Listen to our episode with Karim Kurmaly from Veramaris!Check out our new website!: https://www.globalseafood.org/podcastFollow us on social media!Twitter | Facebook | LinkedIn | InstagramShare your sustainability tips with us podcast@globalseafood.org or leave us a voicemail at +1 (603) 384-3560!If you want to be more involved in the work that we do, become a member of the Global Seafood Alliance: https://www.globalseafood.org/membership/

Episode 97: In this Research Unpacked episode Alistair McKenzie chats to Tim McGrath. Tim is an Australian Sports Physio based in Canberra, with over 15 years experience in professional sport and 20 in clinical practice. He completed his PhD from the Research Institute of Sport & Exercise at the University of Canberra on ACL rehabilitation and return to sport in 2016 and is the clinical & research director of Pitch Ready which focuses on blending clinical insights with data science, squad-based injury prevention and return to sport testing following lower limb injury. In this episode Alistair and Tim discuss his insights and work on ACLR Rehab.          Topics discussed:        Undergoing a PhD and completing applied research  Clinical tests used in ACLR rehab and relevance to practise The Influence graft type has on ACLR recovery          Reference   McGrath, T. M., Waddington, G., Scarvell, J. M., Ball, N., Creer, R., Woods, K., Smith, D., & Adams, R. (2016). An Ecological Study of Anterior Cruciate Ligament Reconstruction, Part 1: Clinical Tests Do Not Correlate With Return-to-Sport Outcomes. Orthopaedic journal of sports medicine, 4(11)     https://pubmed.ncbi.nlm.nih.gov/27900339/           Where you can find Tim:     Twitter  LinkedIn Research Gate       Sponsor Inform Performance is sponsored by VALD Performance, makers of the Nordbord, Forceframe, ForeDecks and HumanTrak. VALD Performance systems are built with the high-performance practitioner in mind, translating traditionally lab-based technologies into engaging, quick, easy-to-use tools for daily testing, monitoring and training       Keep up to date with everything that is going on with the podcast by following Inform Performance on:     Instagram Twitter Our Website     Our Team     Andy McDonald Ben Ashworth Alistair McKenzie

Light Townsend is Chief Legal Officer at Green Point Research, a vertically-integrated hemp biomass originator and processor, and author of Modern Captive Insurance: A Legal Guide to Formation, Operation, and Exit Strategies. Use the promo code "Sweatequity25" for 25% off CBD roll-ons and softgels at Satividol.com and Delta 8 products at thegramco.com   Episode sponsor: Get 70% off Viome's Gut Intelligence Tests and Supplements with our link for health insights, personalized food recommendations, and precision supplements, formulated just for you https://viomehq.sjv.io/sweq69

“A key part of how I go about doing my research is being involved in policy discussions, policy conversations, and also by following the international climate negotiations very closely. Actually, I started my research career as a part of the Presidency of the International Climate Negotiations in 2009. After that I remained an advisor to country delegations in the international negotiations, particularly small island development states or least developed countries. That really helped me to get a sense of what the real questions are that they are struggling with.”Dr. Joeri Rogelj is Director of Research at the Grantham Institute at Imperial College and also at the International Institute for Applied Systems Analysis. He studies how societies transform towards more sustainable futures, connecting Earth sciences to policy. He publishes on 1.5°C pathways, UN climate agreements, carbon budgets and net zero targets. He is a long-serving author on authoritative science assessment reports of the UN Environment Programme and Intergovernmental Panel on Climate Change.· www.imperial.ac.uk/people/j.rogelj· www.oneplanetpodcast.org · www.creativeprocess.info

Dr. Joeri Rogelj is Director of Research at the Grantham Institute at Imperial College and also at the International Institute for Applied Systems Analysis. He studies how societies transform towards more sustainable futures, connecting Earth sciences to policy. He publishes on 1.5°C pathways, UN climate agreements, carbon budgets and net zero targets. He is a long-serving author on authoritative science assessment reports of the UN Environment Programme and Intergovernmental Panel on Climate Change.· www.imperial.ac.uk/people/j.rogelj· www.oneplanetpodcast.org · www.creativeprocess.info

My guest this week is Dr.Tami Meraglia. In this episode, Dr. Tami and I discuss her favorite hormone, testosterone. Not surprising since she is the author of The Hormone Secret. Testosterone is often a misunderstood and underappreciated hormone, especially for women. Did you know testosterone plays a really important role in women's health? Find out why as Dr. Tami walks us through many examples of women feeling much better when their testosterone levels were regulated. We discuss other important hormones involved in sleep, gut health, mental health. Optimizing hormones can help people to feel good enough to keep going on their healing journey.  Learn more about Dr.Tami on her website at https://drtami.com/ or reach out to her clinic by emailing support@drtami.com. Sponsor Offer:Oxford HealthSpan brings us Primeadine, the best formulated Spermidine supplement on the market!  What makes it stand out – it includes Spermine & Putrescine two other Polyamines that work hand in hand with Spermidine PLUS FOS, a prebiotic to feed the bacteria in your gut that make Spermidine!  I take Spermidine daily as do my family and my clients – it has become a solid member of my “foundation stack”.  Research has shown that Spermidine upregulates autophagy, helps the immune system to rejuvenate and it protects DNA – visible benefits experienced by myself and my clients include better sleep, hair, skin, and nails!   Sponsor offer: If you haven't tried it yet go to Primeadine.com and use promo code BIONAT15 to save 15% at https://oxfordhealthspan.com/products/best-spermidine-supplement Episode Takeaways: [06:20] How did Dr.Tami get to where she is today?.. [14:00] How much do hormones affect how people feel?.. [17:00] Are people too quick to get on TRT?.. [21:45] How is each patient's care addressed and customized? The three pillars of patient care… [32:42] Focused life force energy and meditation… [42:50] Is HRT dangerous? Do we need HRT or are there alternatives?.. [47:00] Thoughts on contraceptives that stop ovulation… [52:49] What are the key hormones that men have issues with besides testosterone?.. [54:00] How sleep affects hormones.. Are you a mouth breather?.. [61:50] Aromatase inhibitors and natural alternatives…   Follow Nat: Facebook Facebook Group  Instagram Work with Nat: Book Your 20 MInute Optimization Consult

Since low carb and high fat diets are all the craze right now, I thought I'd share some interesting research on mitigating the harmful effects of certain high fat diets on your health…   It's interesting, but nature has once again given us a compound to dampen the oxidative and inflammatory stress we can put on our body when not careful…   So on today's #CabralConcept 2174 I'd like to share the amazing research on a high-fat diet and how reseveratrol can negate the effects - Enjoy the show and let me know if you have any questions or comments! - - -   Show Notes & Resources: http://StephenCabral.com/2174 - - - Dr. Cabral's New Book, The Rain Barrel Effect https://amzn.to/2H0W7Ge - - - Join the Community & Get Your Questions Answered: http://CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Stress, Sleep & Hormones Test (Run your adrenal & hormone levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels)

Imagine nature inspiring us to create robots of the future! Kevin explores the future with Dr. Daniela Rus, who heads MIT's CSAIL program. Hear about the latest research on everything from AI & ML to Human-Computer Interaction and Computational Biology.  Daniela Rus Kevin Scott  Behind the Tech with Kevin Scott  Discover and listen to other Microsoft podcasts.

Joy Bivins, director of the Schomburg Center for Research in Black Culture, talks about first year leading the Center, also to catch the final week of their Subversion & The Art of Slavery Abolition exhibition and discusses the collection originated by Arturo Schomburg with it's value in teaching Black history. 

E.O. Wilson was sometimes called "the father of biodiversity," sometimes "a modern-day Darwin," and sometimes simply "Ant Man." His recent death was an enormous loss to the world of biology and environmentalism.  You'll hear him tell wonderful stories here, including one about how a childhood disability gave him a great advantage in his work. You'll also get to know two major figures in a related field: ethnobotany. Richard Schultes created the field with his groundbreaking studies in the Amazon, back in the 1940's & 50's. He studied the plants that the indigenous populations used for healing, in an effort to identify new molecules that could be used in modern medicine. Along the way, he discovered over 2,000 plants previously unknown to science. One of Schultes' proteges was Wade Davis, who furthered the work of ethnobotany, and today is a best-selling author of books about indigenous cultures around the world.

Pat Mayo provides a quick preview and makes his early 2022 American Express Picks in a his first look and research for this week's PGA event. #AmericanExpress #FantasyGolf #PGATOUR Get 20% All DK Tools/Stat Engine: https://www.fantasynational.com/mayo NFL Stats & Tools Code “MAYO” for discount: https://www.runthesims.com/mayo Use code MMN at Prize Picks for a deposit match up to $100: https://bit.ly/PrizePicksMMN Join Mayo Media Newsletter: https://mayomedia.substack.com/people/32468255-mayo-media Sub to the Mayo Media Network: https://bit.ly/YTMMN NFL Stats & Tools Code “MAYO” for discount: https://www.runthesims.com/mayo NFL RESEARCH: https://youtu.be/YwfMLloiX1k How to Play NFL DraftKings, Strategy & Tips: https://youtu.be/pXkjPOwv5I4 SHOW INDEX 00:00 Intro 1:39 Course + Field 9:29 Event History 11:33 Field 14:23 Stats + Model 31:52 SG: Sony MCs Apple: http://bit.ly/PMEiTunes Spotify: https://goo.gl/VboemH Stitcher: http://goo.gl/Ft3Gmr Google: http://bit.ly/GooglePodPME Castbox: http://bit.ly/PMECastbox